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ABSTRACT 
Herbal medicine is widely used, especially in developing countries because it is 
readily available and affordable. In Ghana, most people depend on herbal medicine 
to meet their basic healthcare needs. Though herbal medicine has been in use over a 
long period of time, sufficient scientific data supporting the claimed therapeutic 
benefits of medicinal plant formulations for human ailments is limited. Whilst much 
of the global research efforts on the therapeutic potential of medicinal plants focus 
mainly on the screening for phytochemical constituents, antimicrobial efficacy, and 
toxicity, there is the need to investigate not only potential benefits but also 
deleterious effect of these herbal medicinal products on human health. 
The major aim of this investigation was to screen commonly marketed herbal 
medicinal products on the Ghanaian market for their mutagenic potential using the 
bacterial reverse mutation assay (Ames test). The Salmonella typhimurium mutant 
strains TA98, TA100 and TA1537 were employed using 2 different concentrations 
(1mg/mL and 8mg/mL) of the herbal formulations based on their protein and 
carbohydrate concent. The test was carried out using induced (S9-activated and 
Rifampin-activated S9 microsomal fractions prepared from adult pig liver). The 
antimicrobial properties of commonly marketed Ghanaian medicinal plant product 
formulations. 
Results of the mutagenicity study showed that none of the products tested indicate 
any positive mutagenic effect on the mutant strains tested. On the other hand,one of 
the extracts, E8 containing a combination of aqueous extracts from Clausena anisata, 
Pilostigma thonningii, Trichilia monadelpha, Khaya senegalensis and Nauclea 
latifolia showed a 2-fold  decrease in revertant colonies compared to that of the 
negative controls for all strains in the metabolic activation system of the assay, 
indicating the potential antimutagenic activity of the combined extract. Extract E8 
also showed bactericidal activity against Moraxella catarrhalis, a causative agent of 
otitis media in children, particularly affecting the Australian Indigenous community. 
The minimum inhibitory concentration (MIC) and the minimum bactericidal 
concentration of E8 against M. catarrhalis was 125µg/mL and 500µg/mL 
respectively. None of the other extracts showed antimicrobial activity against  the 
pathogens tested in this investigation. 
vi 
 
It thus appear, that one or more of the plant constituents in E8 formulation may 
contain bioactive compounds responsible for the observed antimicrobial activity. 
Furthur investigations to determine the plant constituents of E8 contributing to the 
antimicrobial and antimutagenic activities are clearly warranted. 
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The aims/objectives of the study are as follows: 
 Screeen commonly marketed herbal medicinal products on the Ghanaian 
market for their mutagenic potential using the bacterial reverse mutation 
assay (Ames test) 
 
 Determine the antimicrobial properties of commonly marketed Ghanaian 
medicinal plant products using a multiplicity of pathogens. 
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Outline of thesis 
This thesis has been prepared using a hybridization format of submitted and/or 
prepared manuscripts, with individual chapters on introduction and background 
review, materials and methods, supplementary results for Ames test, general 
discussion, conclusion/future directions/study limitations and references. 
CHAPTER 1 – (1.1 and 1.2) Introduction and background review of Ames test 
 
CHAPTER 1 - 1.3 : In this section of the chapter, a comprehensive review of 
literature of the individual plant constituents of the nine Ghanaian medicinal plant 
formulation was undertaken. This consisted of their general description, traditional 
uses, phytochemical constituents, antimicrobial activities, anti-parasitic activities, 
pharmacological studies, cytotoxicity and genotoxicity studies. 
 
CHAPTER 2 – General Materials and Methods that could not be accommodated in 
the manuscripts are described in this chapter. 
 
CHAPTER 3 – The mutagenic potential of nine (9) commonly marketed Ghanaian 
aqueous medicinal plant formulations were tested against Salmonella typhimurium 
mutant strains TA98, TA100 and TA1537 at a concentration of 1mg and 8mg/mL 
based on their protein and carbohydrate concentrations using Ames test. This test 
was performed for both induced (S9 activated and S9+Rifampin activated) and un-
induced (without metabolic activation) pre-incubation method. None of the extracts 
tested positive for mutagenicity. However, one extract, E8 was found to  produce a 2-
fold decrease in revertant colonies as compared to the negative control, indicating 
antimutagenic activity of product E8. 
 
CHAPTER 4 - Supplementary information for herbal extracts demonstrating 
negative outcomes in the Ames test for all Salmonella typhimurium strains which 
were not submitted for publication is presented in this chapter. 
xiv 
 
CHAPTER 5 - Antimicrobial activity of the Ghanaian medicinal plant products, 
performed using agar well diffusion and microdilution method for minimum 
inhibitory concentration (MIC) and minimum bactericidal concentrations (MBC) as 
described. The extracts were tested against Streptoccocus pyogenes, Streptococcus 
agalactiae, Klebsiella pneumonia, Pseudomonas aeruginosa, Escherichia coli, 
Moraxella catarrhalis, Bordetella parapertussis, Acinetobacter baumannii, 
Salmonella typhimurium and Candida albicans, at 20mg/mL. Of the nine extracts 
tested, Extract E8 showed bactericidal activity against Moraxella cataarhalis with an 
MIC of 125µg/mL and MBC of 500µg/mL. 
 
CHAPTER 6 – General Discussion 
 
CHAPTER 7 – Conclusion and future directions 
 
REFERENCES – This consist of all references cited in this thesis 
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Chapter One  
Introduction and Literature Review 
 
1.1 Introduction 
Herbal medicine is “a plant- derived material or preparation with therapeutic or other 
human health benefits which contains either raw or processed ingredients from one 
or more plants” (World Health Organization (WHO, 1993). Many plant species used 
in herbal medicine have been found to contain active compounds, which can be 
extracted and used as traditional drug alternatives. The plant can also be used either 
directly or as an extract (crude extract) for medication, a practice which is common 
in developing countries (Ishii et al., 1984; Hoyos et al., 1992). Herbal medicine plays 
a significant role in Africa, and has also maintained its popularity worldwide. About 
80% of African and Asian populations, including Ghana, depend on herbal remedies 
as alternative to orthodox medicine for their primary health care. Even in many 
developed countries, 70% to 80% have used some form of alternative or 
complementary medicine at least once (WHO, 2008). Herbal medicine is also the 
first line of treatment  for about 60% of children with malaria in Countries like 
Ghana, Nigeria, Zambia and Mali (WHO, 2003), because of the easy and affordable 
access to herbal medicine. ). In Ghana, it is estimated that 951 tons of crude plant 
medicine (excluding pre-packed herbal medicine) are sold annually on the Ghanaian 
domestic market, amounting to a total of US$7.8 million market value and an export 
value of US$15 million ( Van Andel, Myren and Van Onselen, 2012). Medicinal 
plants have been used as antimicrobial, antidiabetic, anti-atherogenic, antioxidants, 
anti-cancer and anti-malarials (Afolayan and Sunmonu, 2010; Afriyie et al, 2013; 
Aquil, Ahmed and Mehmood, 2006; Azas et al, 2002; Boakye-Yiadom, 1979 Khan 
et al, 2012; Sawadogo et al, 2012; Tempesta, 2010).  
 
Based on their long-term use without adequate scientific research, many people 
believe that herbal medicines are safe and have either low or no toxicity. However, 
some herbal medicines can have harmful adverse reactions due to the presence of 
toxic constituents (Zink and Chaffin, 1998). In some African countries, herbal 
medicines have been reported to be responsible for 0-35% of cases of acute renal 
failure (ARF), (Foyaca-Sibat, Ibañez-Valdѐs and Awodetu, 2001). For instance in 
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Kenya, about 10.9% of all cases of ARF over a period of two years was attributed to 
the use of herbal remedies (Otieno, McLiqeyo & Luta, 1991). Chinese herbs 
containing the plant ingredient aristolochic acid has also been suggested to cause 
urinary bladder cancer and end-stage kidney failure (Cosyns, 2003; Laing et al, 
2006). Other research findings have also indicated some plant extracts to be 
mutagenic (Wright et al 2001; Ansah, Khan & Gooderham, 2005; Rojas, Wright, 
Pina & Portugal, 2008; Gopalan et al, 2011) and cytotoxic (Higashimoto et al., 1993; 
Haq, 2004; Plewa and Wagner, 1993), raising some concern about the long-term use 
of such medicinal plants.  
 
The aim of this project was to screen commonly marketed herbal medicinal products 
on the Ghanaian market for their mutagenic potential using the bacterial reverse 
mutation assay (Ames test). The assay is specifically designed to detect the 
mutagenicity of a wide range of compounds and biological molecules capable of 
producing genetic damage leading to gene mutations. Validation tests have also 
shown a high predictive value for rodent carcinogenicity with a positive Ames test 
(MaCann and Ames, 1976; Zeiger et al., 1990). The test was be carried out with and 
without metabolic activation, since some potential mutagens need to be metabolized 
in the liver to produce biologically active potential carcinogens.  
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1.2 Background Literature Review of Ames test 
1.2.1 Ames test 
The Salmonella/microsome reverse mutation assay, referred to as Ames test, was 
previously developed by Bruce Ames (1971) to detect the mutagenic potential of 
chemical substances, as well as a wide range of environmental and biological 
compounds in mixtures (Maron and Ames, 1983). Chemical mutagens detected by 
the Ames test have subsequently been shown to be carcinogenic in animals, and 
carcinogens also found to be mutagens. These include aflatoxin B1, mitomycin C, 
daunomycin, fungal toxins, and cigarette smoke condensate (Ames, McCann and 
Yamasaki, 1975; Ames, 1972; Ames, Lee and Durston, 1973); Maron and Ames, 
1983; Mortelmans and Zeiger, 2000).  The Ames test is also used as an initial 
screening test worldwide for the registration of new drugs and chemicals by 
regulatory agencies (Maron and Ames, 1983; Mortelmans and Zeiger, 2000). The 
test employs Salmonella typhimurium auxotrophs, which are histidine deficient 
mutant strains of Salmonella typhimurium. Each strain has different type of mutation 
in the histidine operon. In addition to this, the strains have DNA repair mutation in 
the rfa genes determining biosynthesis of somatic lipopolysaccharide core of the S. 
typhimurium strain, with or without the presence of plasmid pKM101. This plasmid 
imparts ampicillin resistance and also the ability of the test to detect mutagens as a 
result of reverse mutation of rfa genes (Maron and Ames, 1983). 
Table 1  
Characteristics of Salmonella typhimurium strains  
 
Salmonella 
Strain 
Gene 
Affected 
DNA 
Repair 
LPS Biotin 
Requirement 
R Factor 
Plasmid 
Mutational 
Event 
TA98 hisD3052 uvrB rfa bio- pKM101 Frameshift 
TA100 hisG46 uvrB rfa bio- pkM101 Base-pair 
substitution 
TA1537 hisC3076 uvrB rfa bio-      - Frameshift 
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1.2.2 Properties of Salmonella typhimurium auxotrophs 
1.2.2.1 DNA repair mutation 
The uvrB gene, which encodes uvrB protein, that is induced by UV light and some 
chemical mutagens, which in coordination with uvrA and uvrC, causes damage to 
DNA repair mechanisms. The presence of this mutation makes the auxotrophs more 
sensitive to chemicals capable of inducing damage. The mutation also extends to the 
gene required for biotin synthesis, hence the need to add biotin to the test system 
(Hsu et al, 1995). The uvrB mutation is indicated by sensitivity to UV light. 
1.2.2.2 rfa mutation  
Salmonella typhimurium strains defective in the rfa gene result in defective 
lipopolysaccharide layer of the bacterial cell, making the outer membrane of the cell 
more permeable to large molecules (Parry and Parry, 2012). The presence of rfa 
mutation is indicated by sensitivity to crystal violet. 
1.2.2.3 R factor plasmid (pKM101) 
Plasmid pKM101 is a conjugate plasmid that codes for transmissible drug resistance. 
pKM101 is derived from R46 by deletion of a single region of DNA. The plasmid 
codes for β-lactamase that makes the strains resistant to ampicillin. It increases 
cellular survival after UV radiation, chemical and spontaneous mutagenesis (Walker 
et al, 1975). 
1.2.2.4 Histidine Biosynthesis Pathway 
Salmonella typhimurium wild-type strains are able to grow on culture media without 
the addition of amino acids. This is due to the availability of enzymes required for 
histidine synthesis in the pathway.  Salmonella typhimurium auxotrophs on the other 
hand are mutants, his- (histidine-dependent) due to mutations in a gene which is 
required in the production of histidine. The strains have G-C base pairs at their site of 
reversion, thus, -C-C-C in base pair substitution and –C-C-C-C-C-C- or –C-G-C-G-
C-G-C-G in frameshift strains (Levin et al, 1982). The his- auxotrophs require an 
external source of histidine to grow unless there is a reversion of the mutation which 
will allow histidine production. The histidine biosynthesis pathway is composed of 
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ten enzymatic steps and eight genes. Three out of the eight genes, hisD, hisB and 
hisI, encodes bifunctional enzymes and two other genes, hisH and hisF encode 
polypeptide chains. Figure 1 shows the histidine biosynthesis pathway (Alifano et al, 
1996). 
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Histidine biosynthesis pathway Souce: Alifano et al, 1996 
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1.2 
 
Fidelia Senayah, Trilochan, K. Mukkur (2014). “A Review of the 
Biological Activities and Traditional uses of Plant Constituents in some 
Ghanaian Medicinal Products”. IJIMP. 
 
 
Manuscript of this section on literature review of the medicinal plants 
was accepted on November 17, 2014 for publication in the next issue of 
International Journal of Indigenous Medicinal Plants, IJIMP (Article ID: 
27703994). Impact factor of this Journal is 3.51. 
The manuscript is attached on the next page. 
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Abstract 
Medicinal plants are widely used, especially in developing Countries. These 
medicines have become an important part of the primary health care delivery system, 
hence their use in the treatment of many ailments. In Ghana, as is the case with most 
other developing countries, many people depend on herbal medicine to meet their 
basic health care needs because of ease of accessibility and affordability. This review 
aims at providing update on the traditional uses and biological activities of medicinal 
plants found in commonly marketed herbal medicines in Ghana. 
Keywords: Medicinal plants, biological activities 
Introduction 
Herbal medicines play significant role all over the world. Most African nations are 
endowed with rich natural plant vegetation and these plants have been in use since 
ancient days. Many plant species used in herbal medicine have been found to contain 
active compounds, which can be extracted and used as traditional drug alternative. 
The plant can also be used either directly or as an extract (crude extract) for 
medication, a practice which is common in developing countries (Ishii et al., 1984; 
Hoyos et al., 1992). The World Health Organization (WHO) estimates that about 
80% of African and Asian population relies on herbal remedies as alternative to 
orthodox medicine. It is also estimated that in Ghana, herbal medicine is the first line 
of treatment for children with malaria (WHO, 2003). Medicinal products sold on the 
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Ghanaian markets are usually in the form of finished products which are indicated 
for the treatment of common ailments such as malaria, typhoid fever, haemorrhoids, 
management of diabetes and hypertension among others. These products may be 
prepared form one plant or combination of two or more plants. However, raw plant 
parts are also readily available and sold on the market as well. The main objective of 
this review is to highlight the biological activities of individual plants commonly 
found in medicinal products sold on the Ghanaian Market. 
Medicinal Plants Commonly used in Ghana and Their Biological Activities 
Nauclea latifolia (Sm)  
Description: Nauclea latifolia belongs to the family Rubiaceae and is mostly found 
in tropical Africa and Asia but also cultivated worldwide. It is commonly called 
African peach or pin cushion tree. Its local Ghanaian names are: Paye biasa, kisia, 
oyefa, Kankanu (Twi), ekusiawa (Fante), Nyimo (Ewe), Oyeta-owefa (Ga), Gulun 
gun (Dagbani). It is a straggling multi-stemmed shrub or small tree that grows up to 
about 4m high. The leaves are broadly elliptic to rounded-ovate, bark rough, flowers 
white or yellowish white and fragrant, fruit reddish [4]. 
Traditional Uses: Almost all parts of N. latifolia are used in traditional medicine for 
therapeutic benefits. In West and South Africa, the leave and bark are used in the 
treatment of diarrhea, malaria and stomach pains ([5], [6]). In Nigeria, it is used as a 
remedy for stomach ache and tuberculosis [7]. In Ghana, the roots, bark and leaves 
are also used for the treatment of arthritis, malaria, oliguria, halitosis, infective 
hepatitis and jaundice [4]. 
Phytochemical Constituents: Phytochemical analysis of aqueous and methanol 
extracts of the leaves, stem bark and roots has shown the presence of saponins, 
alkaloids, glycosides tanins and flavonoids [8]. 
Antimicrobial Activity: The methanol, hexane and aqueous extracts of leaves and 
stem bark of N. latifolia is reported to have inhibitory effects on wild strains of 
Escherichia coli, Streptococcus pneumoniae, Shigella dysenteriae and 
Staphylococcus aureus [8]. Other broad spectrum antimicrobial activities have also 
been observed ([9], [10], [11]). Wound healing and antidiarrheal activity of the stem 
and root backs was also observed in rabbits and diarrheal induced rats [12]. 
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Pharmacological Studies: Extract of the plant is reported to significantly reduce, the 
level of plasma cholesterol in albino rats, an indication of its hypocholesterolemic 
effect [13].  The root and stem have also been shown to antihypertensive properties, 
reducing serum sodium and chloride levels in male and female albino Wister rats; the 
root extract reduced systolic, diastolic and mean arterial pressure in normotensive 
and hypertensive rats ([14], [15]). Ngo et al., 2009 [16] reported the sedative, 
anticonvulsant and anxiolytic-like effects of the root back in animal models. The root 
bark also showed antipyretic, antinocieptive and anti-inflammatory effects in mice 
and rats ([17], [18]). It reduced uterine contraction induced by oxytocin, 
acetylcholine and ergometrine in non-pregnant female albino rats [19], thus 
supporting its use as anti-abortifacient. The root also exhibited antidiabetic activity in 
STZ-induced diabetic rats [20]. However, the aqueous extract of the stem has 
hepatotoxic and nephrotoxic potential [21].  
Anti-parasitic Activity:  N. latifolia has been reported to possess shown 
antiplasmodial activity against both chloroquine-resistant and chloroquine-sensitive 
strains of Plasmodium falciparum ([22], [23]). The ethanol root extract is also 
reported to have decreased the level of parasitaemia in mice experimentally infected 
with Trypanosoma brucei brucei [24]. Makai and Kobo, 2008 [25] reported a similar 
anti-trypanosomal activity of the stem bark on Trypanosoma congolense. The leaf 
extract killed the infective larvae stage of gastrointestinal nematodes in sheep [26]. 
Genotoxic and Cytotoxicity Studies: Saponins from the hydromethanolic extracts 
of N. latifolia was observed to exhibit genotoxic activity in the micronucleus and 
comet assays by inducing synergistic DNA-damage in vitro and chromosome 
mutations in mammalian cells [27]. Alkaloid rich chloroform extract of the plant is 
also reported to be mutagenic in the presence of metabolic activation with 
Salmonella typhimurium mutants TA97 and TA100. It induced single-strand breaks 
in human lymphocytes [6].  Relatively low cytotoxicity in different cell lines has also 
been reported Zirihi et al., 2005 and Ajaiyeoba, 2006 ([23], [28]). 
Phyllanthus fraternus (Webster) 
Description:  Phyllanthus fraternus belongs to the family Euphorbiaceae. It is native 
to India, Amazon rainforest and also available in other tropical Countries. In Ghana it 
is called Nambu (Hausa), Ofobiokpai (Dangme), Adfiehotsui (Ewe), Nkatsena 
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(Fante) Awomma agu wakyi, Awobe (Twi). It is a glabrous annual herb which grows 
up to about 30-40cm high. The stem is smooth with slightly winged branchlet. 
Leaves elliptic, round at both ends ([4], [29]). 
Traditional Uses: P. fraternus is used traditionally for the treatment of fever, 
dysentery, diabetes, jaundice, as a diuretic, stomach ache ([30], [31]), gynaecological 
disorder [32], viral infections, wound, fracture [4], liver, intestinal and bladder 
disorders [33]. 
Phytochemical Constituents: The plant contains reducing sugars, glycosides, 
steroids, alkaloids, tanins, saponins and flavonoids [33]. 
Antimicrobial Activity: Extracts of P. fraternus has been reported to be effective 
against clinical (wild) isolates and World Health Organization (WHO) strains of 
Neisseria gonorrhoeae [34]. 
Pharmacological Studies: Aqueous extracts of P. fraternus has been shown to have 
significant protective effect on the mitochondrial dysfunction of rats induced with 
carbon tetrachloride [35]. Similar hepatoprotective effect against carbon tetrachloride 
and galactosamine induced toxicity has been demonstrated by Khatoon et al., 2006 
[33]. P. fraternus has been reported to have protective effect against cytotoxicity 
induced by lead and aluminum salts [36].  The plant extract produced significant 
inhibition of capsaicin-induced neurogenic pain, formalin-induced pain and acetic 
acid induced abdominal constriction in Swiss mice [37]. It also showed protective 
effect against superoxide radicals and alcohol-induced oxidative stress in liver 
mitochondria of rats. The ability of the plant to prevent or reduce deterioration 
caused by free radicals was also demonstrated by Naga et al., 2008 [38] and similar 
antioxidant activity has also been reported by Koffuor and Amoateng, 2011[39]. 
Cryptolepis sanguinolenta  
Description: Cryptolepis sanguinolenta belongs to the family Periplocaceae. It is 
mostly found in tropical West Africa. It is also known by local Ghanaian names such 
as Kadze (Ewe), Nibima (Twi) and Gungnamau (Hausa). It is a tropical shrub with 
thin branches measuring up to 8m high. Leaves are oblong-elliptic, ovate, acutely 
and shortly acuminate. The leaves and roots are yellow in appearance ([4], [40]).  
Traditional Uses: Aqueous extracts of C. sanguinolenta are traditionally used to 
treat acute malaria, hypertension and inflammatory conditions [41]. In Ghana, it is 
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commonly used in the treatment of fever, malaria, insomia, urinary and upper 
respiratory tract infections [42]. 
Phytochemical Constituents: Phytochemical screening of aqueous and ethanol 
extracts has showed the presence of alkaloids, reducing sugars, polyuronides, and 
anthocyanosides [43]. 
Antimicrobial Activity: Aqueous and organic of C. saguinolenta root have been 
reported to have exhibited antibacterial activity against both methicillin-resistant and 
methicillin-sensitive [44]. Cryptolepine, an indoloquinoline alkaloid of C. 
saguinolenta has been shown to have activity against S. aureus, E. coli, Candida 
albicans, Saccharomyces cerevisiae and Camppylobactor species and Vibro cholera 
([45], [46], [47]). Cryptolepine hydrochloride, a salt of the alkaloid also inhibited the 
growth of Mycobacterium species suggesting its anti-mycobacterial properties [48]. 
Other fractions of C. saguinolenta extract have also shown antimicrobial properties 
([49], [50], [43]). 
Antiplasmodial Activity: Both in-vitro and in-vivo studies on C. sanguinolenta have 
shown its effectiveness in the treatment of malaria. Clinical study of the efficacy of a 
tea-bag formulation in patients with uncomplicated malaria showed the ability of the 
extract to clear parasitaemia in over 50% of patients within 72 h ([51], [52]). 
Cryptolepine was highly active against multidrug resistant strains (KI) of P. 
falciparum [53]. 2-Bromoneocryptolepine and other derivatives of neocryptolepine, 
an alkaloid of C. sanguinolenta has been shown by Jonckers et al., 2002 [54] to have 
antiplasmodial action against chloroquine-resistant P. falciparum (Half maximal 
inhibitory concentration, IC50 4.0µM). Cryptolepine derivatives administered orally 
to mice infected with P. berghei showed reduction of parasitaemia by 89% with the 
most potent compound being 2, 7-dibromocryptolepine [55]. Other antiplasmodial 
activities have been reported by Addae-Kyereme 2004 and Rocha et al., 2012([56], 
[57]). 
Pharmacological Studies: Cryptolepine and its salts; hydroiodide, hydrochloride 
and hydrotrifluoro-methanesulfonate have been reported to have lowered blood 
glucose in rodent models with type II diabetes [58]. The effect of aqueous root 
extract on reproductive and foetal development in mice has also been studied by 
Ansah et al., 2002 [59]. The extract was reported to have reduced female fertility 
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(100% to 0%) and terminated pregnancy in 60% of mice treated during gestation, 
with 37.0% intrauterine growth inhibition and 12.0% foetal mortality. The alkaloids, 
cryptolepine and11-hydroxycryptolepine, have been reported to possess 
antimuscarinic and antioxidant properties ([60], [61]). 
Genotoxicity and Cytotoxicity Studies: Cryptolepine is reported to exhibit 
cytotoxic effects on P388 human leukemia cell lines [62]. It also induced mutation at 
the hprt locus and micronuclei formation in V79, a Chinese hamster lung fibroblast 
cell line [63]. DNA damage in human lymphocytes caused by cryptolepine and its 
analogues has been reported by Gopalan et al., 2011 [64]. The potential of the 
alkaloid to intercalate into DNA promoting DNA lesions was also observed in S. 
cerevisiae [65]. There are also similar findings on cytotoxicity/DNA intercalating 
activity of cryptolepine and its derivatives ([66], [54], [57]). 
Ocimum gratissimum  
Description: Ocimum gratissmum is a member of the family Lamiaceae (Labiatae). 
It is native to tropical Africa, Southern Africa, Western Indian Ocean and Asia. It is 
commonly called basil or tea bush.  Other local names are Nunum, onunum (Twi), 
Bebusui, Dzeveti (Ewe), Sulu (Ga), Dardoyatagida (Hausa). It is a perennial aromatic 
herb, with stem measuring about 1-3m long. It is round-quadrangular, branched and 
globorous or pubescent. The leaves are broad, 5-13 cm long and 3-9 cm wide [67].  
Traditional Uses: O. gratissimum is used traditionally to treat upper respiratory tract 
infections, skin diseases, cough, diarrhea, conjunctivitis and headache [68]. It is also 
used for the treatment of malaria, dyspepsia, rheumatism, dysentery, sinusitis, fever 
and snake bites [4]. 
Phytochemical Constituents: Phytochemical analysis has shown the presence of 
saponins, steroidal terpenes, glycosides, flavonoids, alkaloids, resins, and tannins 
[69]. 
Antimicrobial Activity: The essential oil of O. gratissimum is reported to have 
antibacterial activity against Shigella flexineri, S. enteritidis, E. coli and Klebsiella 
species. Leaf extracts also showed activity against Proteus mirabilis, S. aureus and 
E. coli ([70], [71]) and other silimar clinical isolates ([72], [69], [73], [74]). The 
extract is reported to have anti-diarrhoeal effect on castor oil induced diarrhea in rats 
[75] and clinical isolate [68]. Its ability to increase vascular permeability, hence 
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wound healing was observed in rabbits [76].  Kishore et al., (200), [77] demonstrated 
the activity of O. gratissimum against Scopulariopsis brevicaulis which causes skin 
mycosis and Cryptococcus neoformans which is common in HIV infected patients. 
Other antifungal activity has been shown in Candida species [78]. The Chloroform 
fraction (92%) and eugonol (16%) inhibited the activity of clinical fungal isolates 
[79]. The activity of leaf extract on in vitro replication of HIV-1 and HIV2 is 
reported by Ayisi and Nyadedzor 2003, [80]. 
Anti-parasitic Activity:  The essential oil and eugonol had inhibitory effect on the 
growth of the Herpetomonas samuelpessoai, a trypanosomatid at a concentration of 
20 to 250µg/ml [81]. It also inhibited the growth of Leishmania amazonensis ([82] 
and Haemonchus contortus, a causative agent of gastrointestinal helmintosis of 
goats, small ruminant animals [83]  
Pharmacological Studies: The leave extract of O. gratissimum is reported to have 
significantly lowered, plasma glucose level in streptozotocin induced diabetic rat 
[84]. This results correlates with earlier work by [85], where O.gratissimum extract 
reduced plasma glucose levels in both normal and alloxan induced diabetic rats by 56 
and 68% respectively. The essential oil and eugonol induced hypotensive effect in 
hypertensive rats. It also relaxed phenylephrine-induced contraction in isolated aorta 
preparations with intact endothelium from rats [86]. A relaxant effect on intestinal 
smooth muscle of guinea pig was also reported by Madeira et al., 2002, [87].  
Reference [88] observed the protective effect of the methanol extract of O. 
gratissimum against ethanol induced hepatotoxicity in male Wistar rats. Other studies 
on acute, sub-acute and gastric tolerance of the oil extract in Wistar rats given at a 
dose higher than 1500mg/kg body weight did not show any adverse effects in the rats 
[89]. Previous toxicity study of the essential oil in rats and mice showed a dose-
dependent sedative effect [90]. The study also demonstrated an inflammatory 
response upon persistent administration of the oil in the rats and mice. An anti-
nociceptive effect of the essential oil of the plant has been studied in two models of 
pain in Swiss male mice. The oil showed a dose dependent inhibition of acetic acid 
induced writhing, causing up to a 60% inhibition at the highest dose of 300mg/kg 
(po). At the same dose range (30, 100 and 300mg/kg), it predominantly inhibited the 
late (inflammatory) phase of formalin induced pain response ([91]. Akinmoladun et 
al., 2007, [92] demonstrated 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical 
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scavenging activity of 84.6% at 250µg/ml and a reduction potential of 0.77 at 
100µg/ml using methanol extract. DPPH scavenging by both polar and non-polar 
extracts was also reported by Oboh et al., 2008, [93]. 
Genotoxicity and Cytotoxicity Studies: Ocimum. gratissimum has been associated 
with anti-carcinogenic and chemo-preventive activities [94]. Organic solvent extract 
of the leaves was shown to be antimutagenic. It inhibited the activity of His- to His+ 
reverse-mutation induced by ethyl methanesulfonate acting on Salmonella 
typhimurium TA100 [95]. The plant has also been reported by Nangia-Makker et al., 
2007, [96] to have inhibited tumour growth and angiogenesis.  
Cnestis ferruginea  
Description: Cnestis ferruginea (Vadhl) D.C belongs to the family Connaraceae. It 
is vastly abundant in Western part of Africa and other tropical regions [97]. Its local 
Ghanaian names are: Apose, Apowse (Twi), Akitase (Fante), Pudaegye (Nzema).  It 
is a shrub of 3–4m in height. Its branches rusty brown. Leaves are indeciduous, 4–
16-jugate with petiole 2–10 cm, rachis 12–27 cm long and densely rusty brown 
pubescent. Lateral leaflets are more or less alternate or sometimes opposite, ovate to 
narrowly oblong, slightly or not unequal at base, and terminal leaflet is elliptic or 
narrowly ovate ([98], [99]). 
Traditional Uses: Aqueous decoction of the roots is used to treat headache, urethral 
discharge, migraine, toothache, skin infections, sinusitis and gynaecological 
conditions [97]. The leaves are used as laxative, for cough, anaemia and for wound 
infections ([99], [4]). Preparations from the back are also used to treat infected gum 
and infantile diseases, whiles the fruit and roots are also used as remedy against 
snake bites [100]. 
Phytochemical Constituents: Phytochemical analysis has shown the presence of 
alkaloids, flavonoids, tannins, saponins, anthraquinones, phenols, glycosides and 
steroids [101]. 
Antimicrobial Activity: Extracts of the root, stem bark and leaves tested against 
clinical isolates showed susceptibility of most gram positive bacteria including β-
haemolytic group A Streptococcus and Bacillus cereus as well as antibacterial 
activity against S. aureus, B. subtilis, E. coli, P. aeruginosa and other clinical isolates  
([102], [103]). 
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Pharmacological Studies: Alkaloid crude fraction of the root has been reported to 
have adverse effect on hepatic function of male Wistar rats. Administration of the 
fraction reduced alkaline phosphatase (ALP) and aspartate transaminase (AST) 
levels; there were increases in serum albumin, conjugated and total bilirubin. 
Histological examination also showed severe disruption of the liver structure and 
presence of red blood cells in hepatocytes [104]. Methanol root extract of the plant 
has been reported by Ishola et al., 2012 [105] to have insignificant effect on the 
weight and vital organs of albino rats. Hepatoprotective effect of the leaf extract was 
also observed in paracetamol induced Swiss albino mice [101]. Toxicity due to the 
presence of compounds dicoumarol and 4-hydroxycoumarin in rabbits has also been 
reported by Vickery and Vickery, 1980 [106]. Purified methanol fractions caused 
leucopenia and in some cases anaemia [107]. Oral administration of ethyl acetate 
extracts (250mg/kg body weight) to streptozotocin (STZ)-induced diabetic rats and 
mice showed a significant reduction in fasting blood glucose (FBG) levels and also 
lowered serum creatinine, total cholesterol, triglycerides and thiobarbituric acid 
reactive species levels. Serum ALT and AST levels were also significantly reduced 
[108]. Amentoflavone isolated from methanol root extract is reported to have 
antidepressant and anxiolytic effect in mice [105]. Aqueous extract of the roots at 
doses of 13, 26 and 52kg/body weight restored to a high extent, sexual functions of 
paroxetine-induced sexual dysfunction in male Wistar rats. The extract also increased 
the levels of luteinizing and follicle stimulating hormones with a corresponding 
decrease in testosterone levels [109]. Cnestis ferrunginea has been shown to have 
prevented gastric ulcer formation in immobilization stress induced gastric ulcer in 
mice [110]. Analgesic and anti-inflammatory property of the plant has also been 
studied. The extract (300-500mg/kg) produced a dose-dependant analgesic effect as 
well as inhibiting carrageenan-induced paw oedema and cotton pellet granuloma 
formation in rats [111]. Similar analgesic and anti-inflammatory activity has been 
reported Ishola et al., 2011, 2012 ([112], [105]. Fractions of  the plant is reported to 
have considerable antioxidant activity using the free radical DPPH assay ([113], 
[101]). 
Genotoxicity and Cytotoxicity Studies: Cnestis. ferrunginea leaves were 
implicated as the source of poisoning in Senegal some years back, where aqueous 
extract was found to be cytotoxic in a cell proliferation assay, XTT [114]. However, 
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in another study, methanol extract of the whole plant gave negative results in the 
bacterial reverse mutation assay. The extract did not cause any increase in His+ 
revertant colonies compared to the negative control even at a higher dose [115]. 
Paullinia pinnata  
Description: Paullinia pinnata belongs to the family Sapindaceae. It is widespread 
in tropical Africa, tropical America and Madagascar. It is commonly called bread 
and cheese plant and locally known in Ghana as Akodwen (Fante), Toantini, 
Obosomfe bese (Twi), Gbadzafeka, Adfiehotsui (Ewe), Gbolantsere (Ga), and Yatsa-
biya (Hausa). It is a woody climber with tendrils, up to 3cm high. The leaves are 
imparipinnate with winged rachis. Inflorescences axillary on long stalks, bearing 
paired coiled tendrils. It has white flowers and fruit about 2.5 cm long which is red 
when ripe [4]. 
Traditional Uses: The leaves are used for the treatment of gonorrhoea, dysentery, 
peptic ulcer, roots for cough, asthma, constipation, female infertility, haemorrhage, 
and the flowers for abdominal pains [4]. It is also used to treat diarrhoea, fracture, 
controlling blood pressure and as an aphrodisiac ([116], [117]). 
Phytochemical Constituents: Presence of carbohydrates, reducing sugars, saponins, 
tannins, cardiac glycosides, anthracene derivatives have been reported 
Osarenmwinda et al., 2009 [118]. 
Antimicrobial Activity: Azelaic acid (a decarboxylic acid) from methanol root 
extract of P. pinnata has shown activity against both Gram negative and positive 
bacteria including resistant strains of S. aureus [117]. A lupeol-3-isovanniloyl ester 
isolated from the plant also demonstrated significant antibacterial activity against 
selected organisms including Clostridium sporogenes and anaerobic C. tetani [119]. 
The methanol extract is reported to exhibit a dose-dependent anti-diarrhoeal activity 
on whole mouse gastrointestinal tract [118]. Wound healing ability has been reported 
in vitro in human dermal fibroblast cell line 142BR and in vivo using excision and 
incision wound models in Sprague-Dawley rats. The methanol extract increased 
142BR cell proliferation at 20µg/ml (94%), tensile strength, hydroxyproline content 
of healing tissue and also decreased epithelisation period and scar area [120]. 
Anti-parasitic Activity: Antimalarial activity of the ethanol leaf extract has been 
demonstrated in Swiss albino mice infected with Plasmodium berghei. The extract 
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suppressed parasitaemia in the early infective stages by 53 to 69%  at 12.5, 25 and 
50mg/kg per day. At the established stage, there was suppression of parasitaemia at 
25 and 50mg/kg by 60%. [121]. Petroleum ether and methanol fractions exhibited 
larvicidal activity against Anopheles gambiae, with petroleum ether extract having 
the highest mortality rate of 100% at a dose range of 125 to 1000µg/ml after 24 hr 
exposure [122]. 
Pharmacological Studies: Biochemical and haematological indices of rats exposed 
to different doses of P. pinnata root extract showed a potential safety up to a dose of 
850mg/kg [123]. Antioxidant activity of the methanol root and leaf extracts has been 
demonstrated by Zamble et al., 2006 [124]. In their study, the extracts were shown to 
induce a slight transcriptional activity of peroxisome proliferator activated receptor-
alpha. The extracts also increased and decreased endothelial nitric oxide synthase 
and endothelin-1 mRNA levels in bovine aortic endothelial cells. Free radical 
scavenging activity on DPPH and 2, 21-azinobis-3-ethylbenzothiazoline-6-sulphonic 
acid radicals showed a strong scavenging activity [125]. Similar DPPH radical 
activity (IC50 of 3.8µg/ml) with methanolic extract has also been reported by Annan 
et al., 2009 [117].  
Genotoxicity and Cytotoxicity Studies: Paullinia. pinnata has been reported to 
have cytotoxic effects on HeLa, cervical carcinoma (25-50% cell proliferation), and 
HT29 colon adenocarcinoma (50-75% cell proliferation) cell lines at 10 and 
100µg/ml [126]. Paullinia. pinnata methanol root extract exhibited moderate 
anticancer activity against human cell lines; DLD-1 and MCF-7 in MTT assay with 
IC50 values 40-55µg/ml [127]. An antiproliferative activity by the plant has also been 
demonstrated in A431 squamous epidermal carcinoma, WM35 melanoma and A2780 
ovary carcinoma cell lines [128]. 
Vernonia amygdalina (Del.) 
Description:  Vernonia amygdalina belongs to the family Asteraceae and is 
commonly called bitter leaf. It is widespread in East and West Africa, but it is also 
grown in North Eastern South Africa and Yemen [129]. Commonly called bitter leaf 
and locally as Tatso (Ga), Biebingira (Dagbani), Gbo, Gboti (Ewe), Awonwone 
(Twi), Ayeanwonle (Nzema). It is a perennial Shrub or small tree up to 10 m tall, 
much branched; trunk up to 40 cm in diameter; bark grey to brown, smooth, 
becoming fissured; young branches densely pubescent. Leaves alternate, simple; 
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stipules absent; Flowers bisexual, regular, 5-merous, strongly exserted from the 
involucre; Fruit a 10-ribbed achene 1.5–3.5 mm long, pubescent and glandular, 
brown to black, crowned by the much longer pappus bristles [130]. 
Traditional Uses: Bitter leaf is used in several dishes especially in West Africa. 
Leaf aqueous preparations are used to treat malaria, measles, dysentery, 
onchorcerciasis, yellow fever, constipation and stomach pain [131]. The root and 
leaves are also used for kidney problems and hiccups ([97], [132]). In Ghana and 
Nigeria, the stem and root bark are used as chewing stick [133]. It is also used to 
treat oliguria, helminthiasis, pruritus, hypertension, cataract and loss of appetite [4]. 
Phytochemical Constituents: Phytochemical constituents found in the extract are 
tannins, alkaloids, saponins, glycosides, flavonoids, reducing sugars and coumarins 
[134]. 
Antimicrobial Activity: Antiviral activity of V. amygdalina fruit has been 
demonstrated in Poliovirus, where it reduced the viral titer by 103 [135]. Methanol 
leaf extract was found to be active against some bacterial isolates at 25mg/ml [136]. 
Crude and solvent fractions of the leaf and bark have also been found to be active 
against E. coli and S. aureus [137]. Similar antimicrobial activity of various fractions 
of the leaves was reported by Shama and Sharma, 2010 [138]. The plant extract 
showed a strong antibacterial activity against S. mutans and S. aureus. It was also 
active against multi-drug resistant gram-negative and gram-positive bacteria as well 
as against standard strains of E.coli (ATCC 25922), S. aureus (ATCC 25923) [139]. 
Ibrahim et al., 2009 [134] also demonstrated the antimicrobial activity of aqueous 
and ethanol extracts on selected foodborne pathogens of medical significance 
including E. coli, S. aureus, Bacillus cereus, Shigella dysentriae and S. typhi. Similar 
antibacterial activity has been reported in other literature ([140], [141], [142]), 
although earlier work by Otshudi, 1999 [143] on diarrhea causing pathogens did not 
show any significant activity. Two Sesquiterpene lactones, vernolide and vernodalol 
isolated from the leaves have been reported to possess both antibacterial (gram-
positive bacteria) and antifungal activities. Venolide had a higher activity with LC50 
values of 0.2, 0.3 and 0.4 mg/ml against Penicillium notatum, Aspergillus flavus, 
Aspergillus niger and Mucor hiemalis. Vernodalol on the other hand, recorded LC50 
values of 0.3, 0.4 and 0.5 mg/ml on the same fungal isolates [144]. 
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Anti-parasitic Activity: Antiplasmodial activity of fractions from V. amygdalina 
leaves has been demonstrated against Plasmodium falciparium in vitro. Petroleum 
ether fraction showed a higher activity with IC50<3µg/ml compared to that of ethanol 
fraction of 5<IC50<10µg/ml [145]. The extract was also found to reduce 
gastrointestinal upset (flatulence and diarrhea) in wild chimpanzee infested with the 
parasite, Ternidens sp. There was reduction in parasitic infection from 1 hr. to 20.5 
hr following ingestion of the extract [146]. However, the leaf extract did not exhibit 
any significant anthelmintic activity when tested against Haemonchus cortortus eggs 
in vitro at concentrations up to 11.2 mg/ml [147]. 
Pharmacological Studies: Antioxidant and cytoprotective activity of boiled, cold 
and methanol extracts of V. amygdalina has been reported to have DPPH free radical 
activity. (14.8 – 36.2%), it also gave a low haemagglutination titer of 0.32 to 5.56 in 
a heamagglutination assay [148]. Aqueous extract of the leaf administered up to 75% 
w/v or v/v to mature BALB/c mice did not show any clinical sign of toxicity [149]. 
An acute toxicity test of aqueous extract on liver function was shown not to be 
hepatotoxic; it had an LD50 of 500mg/kg [150]. Hepatoprotective activity has also 
been reported by Iwalokun et al., 2006 [151]. Pre-administration of the leaf extract to 
acetaminophen-induced hepatotoxicity and oxidative stress in mice in vivo resulted 
in a dose-dependent (50-100mg/kg) reversal of altered liver function parameters by 
51.9 – 84.9%. Similar hepatoprotective activity was reported by Adesanoye and 
Farombi, 2010 [152]. In their work, the methanol leaf extracts reduced carbon 
tetrachloride-induced hepatotoxicity in male rats. Pre-administration of the extract at 
250 and 500 mg/kg doses to the rats before CCl4 (1.2 g/kg body weight) treatment 
resulted in reduction in concentration of serum hepatotoxicity indicator. The extract 
also increased activities of antioxidant enzymes; superoxide dismutase and 
glutathione S- transferase. It has also been reported to have an immunologic effect on 
HIV infected patients, therefore suggesting its use as adjuvant in HIV/AIDS 
management [153]. 
Genotoxicity and Cytotoxicity Studies: Antimutagenic activity of the organic 
solvent extracts of V. amygdalina leaves has been demonstrated by Obaseiki-Ebor et 
al., 1993 [154]. The extracts exhibited inhibitory effects on His- to His+ reverse 
mutation induced by ethyl methanesulfonate on S. typhimurium strain TA100 and 
that of 4-nitro-O-phenylenediamine and 2-aminofluorene on TA98. However, in a 
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cytotoxicity study of the aqueous extract of the plant using Allium cepa assay, [155] 
showed the extract was able to induce chromosomal aberration, which suggests the 
plant could cause genetic damage. Similar induction of cell aberration using Allium 
cepa assay has also been reported by Yekeen et al., 2011 [156].  Vernonia. 
amygdalina has been reported to have anti-cancer effect on human breast cancer cells 
in an in-vitro MTT and Comet assays. Treatment of human breast adenocarcinoma 
cells (MCF-7) at different dose levels showed a significant (P<0.05) reduction of 
MCF-7 cell viability, the comet assay also gave a slight dose-dependent increase in 
DNA damage in MCF-7 cells. There was minmal genotoxic damage in MCF-7 cells 
observed in the Comet assay [157]. The leaf extract has also been reported by Utoh 
and Anastasia, 2010 [158] to inhibit and destroy cancer cells during the early 
formative stages but did not effectively destroy the cells at advanced stages or 
prevent metastasis. 
Momordica charantia  
Description: Momordica charantia is a member of the family Cucurbitaceae. It 
grows in tropical areas such as East Africa, Asia, Caribbean and especially parts of 
the Amazon. It is also cultivated in South America. Commonly known as bitter 
melon, African or wild cucumber and bitter gourd. Other Llocal names are Nyanya 
(Fante), Kakle (Ewe), Daddagu (Hausa) and Nyinya (Twi). The fruit resembles a 
young cucumber, appearing oblong and gourd. The young fruit is emerald green, but 
turns into orange-yellow when ripe. It splits into three irregular valves that curl 
backwards at maturity and releases numerous brown or white seeds encased in 
scarlet arils ([159], [160]). It has simple and alternate leaves with 3–7 deeply 
separated lobes” [161]. 
Traditional Uses: M. charantia or bitter lemon has long been used by the 
indigenous people in the Amazon. They grow it for food and medicine. The leaves 
are used to treat diabetes, hypertension, chicken pox, measles, wounds, fever and 
hepatitis ([160], [4]). The fruit extracts are used against stomach ulcer-causing 
bacteria, Helicobactor pylori and as a contraceptive. The root as astringent also used 
to treat leprosy, leucorrhoea, rheumatoid arthritis, lupus, pruritus, hypertension, 
gonorrhoea, and eczema, as a contraceptive and abortive, glucosuria, appetite 
stimulator, halitosis, haemorrhoids and gout among others [161]. 
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Antimicrobial Activity: M. charantia seed is reported to have significant 
antibacterial activity against S. aureus at 125µg/ml (ATCC 6538) and 125-500µg/ml 
(clinical isolates). It also exhibited a time dependent killing activity after 8 hr 
exposure at 125µg/ml in a time kill assay [162]. The organic extracts of the seeds as 
well as the green parts were also sensitive against Enterococcus faecium with 
inhibition zones of 20-26mm [163]. The leaves have antifungal activity against C. 
albicans, C. tropicalis and C. krusei [164]. M. charantia extracts exhibited antiviral 
activity against Herpes simplex type I and II at < 5µg/ml [165] as well as 
antibacterial and antifungal activities ([166], [167], [168]). 
Anti-parasitic Activity: Crude extract of the fresh fruit of the plant on IV instar 
mosquitoe larvae of Anopheles stephensi, Culex quinquefasciatus and Aedes aegypti 
has been reported. Haxane extract exhibited a higher activity against the three 
mosquitoe species with LC50 values of 66.05, 96.11 and 112.45ppm as compared to 
that of the crude extract at 0.50, 1.29 and 1.45% [169]. Anti-plasmodial activity of 
the aerial part of the plant against mice infected with P. vinckei petteri 279BY and P. 
falciparum chloroquine-resistant strain (Indo) has been investigated. The extract had 
moderate in vivo activity (70 % at 004mg/kg on P. vinckei petteri) and a high 
activity in vitro of 99% inhibition at 10mg/ml against P. falciparum [170]. Amorim 
et al., 1991 [171] earlier reported in their work that both aqueous and ethanolic 
extracts of the leaves were not effective at lowering parasitemia in P. berghei 
infected mice at concentrations of 500 -1000mg/kg [172] has also reported a weak 
anti-parasitic activity. 
Pharmacological Studies: The anti-diabetic activity of M. charantia has been 
reported extensively in literature.The aqueous fruit extract reduced the blood glucose 
levels of rats administered with 50g in oral glucose tolerance test [173]. Fruit extracts 
administered to alloxan-induced diabetic rats over a 3 week period showed a 
significant (p<0.01) drop in blood sugar from 220mg% to 105mg%. Subsequent 
administration of powdered fruit and aqueous extract to severe to mild diabetic 
patients during a clinical trial also showed a significant drop in blood sugar levels, 
with the aqueous extract giving a high fall (54.0%) in blood sugar levels compared to 
the dried powder which gave a 25% fall in blood suger level [174]. Similar study in 
alloxan-induced diabetic albino rats at a single dose of 250mg/kg of extract also 
showed a lowered blood glucose level over a 2 week trial period [175]. Saponin 
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fraction of the fruit extract administered to alloxan-induced hyperglycaemic and 
normal mice induced significant (p<0.05), hypoglycaemic activity in both groups of 
mice [176]. Pure cucurbutanoid compounds isolated from M. charantia is also 
reported to exhibit in vivo hypoglycaemic effects on diabetic male ddYmice strain at 
a dose of 400mg/kg [177]. Reduced adiposity in rats fed on a hyperinsulinemic high 
fat diet (30%) supplemented with fruit extract at a dose of 0.75% or higher (p<0.05) 
has also been reported by Chen et al., 2003 [178].  
Genotoxicity and Cytotoxicity Studies: The seed extract was found to have 
decreased the genotoxic activity of methylnitrosamine, methanesulfonate and 
tetracycline [179]. The fruit extract has also been reported as having antioxidant and 
protective activities in male Wistar rats [180]. Research work by Sharma et al., 2011 
[181] on the anti-carcinogenic effect of the aqueous extract of the fruit in mice, also 
showed extract reduced carcinogen-induced lipid peroxidation in the liver and DNA 
damage in lymphocyte. The extract was also reported to have inhibited tumour 
formation in the mice which had been injected with tumour cells. 
Strophanthus hispidus DC 
Description: Strophanthus hispidus belongs to the family Apocynaceae and occurs 
naturally in savanna woodland and thickest. Arrow poison is the common name and 
it is also known locally as Omletswa, Anama (Ga), Amanfotama, maatwa (Twi), 
Ahoti (Ewe). It is a hairy climbing shrub. The leaves are simple, opposite, elliptic to 
ovate, 5-15cm long and 2-9cm broad. It has white flowers which turns yellow later 
[4]. 
Traditional Uses: The root and leaf are used to treat skin ulcers, leprosy, malaria, 
hypertension venereal disease, yaws, arthritis and the stem for general body 
weakness [4]. Aqueous decoctions of the root and root bark are also used for 
rheumatic disease and oedema [182]. 
Pharmacological Constituents: Saponins, tannins, steroids, flavonoids, alkaloids, 
sapogenetic glycosides are the bioactive molecules present in this medicinal plant 
[183]. 
Antimicrobial Activity: Crude extract of S. hispidus is reported to inhibit the 
activity of S. aureus (NCTC 6571), B. subtilis, E. coli (NCTC 9001), P. aeruginosa 
(NCTC 6570), A. niger and C. albicans at concentrations of 10-100mg/ml [184]. 
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Similarly, the methanol leaf and root extracts of the plant has also been reported by 
[183], to have antibacterial activity against E. coli (ATCC 25922), P aeruginosa 
(ATCC 27853), S. aureus (ATCC 25923) and B. subtilis with MIC values of 2.5-
7.5mg/ml (leaves) and 2.5-10mg/ml (roots). 
Pharmacological Studies: Treatment of carrageenan-induced hind paw oedema in 
rats, xylene induced ear oedema in mice and formalin-induced hind paw oedema in 
mice with the root extract has shown anti-inflammatory properties. The extract 
produced a dose-dependent inhibition of oedema in all groups of animals (p<0.05). It 
also had significant inhibition on inflammatory mediators- histamine, serotonin and 
prostaglandin with the lowest inhibition of 42.8% being observed in serotonin [182]. 
The extract (7.5% w/v) applied topically over wounds 24hr for 24 days showed 
improved healing (Collagenation, re-epitheliasation and rapid granulation formation) 
in excision wound model female Sprague Dawley rats. The leaves and roots extract 
also showed low antioxidant activity in the DPPH assay with IC50 values of 49.8 and 
45.1µg/ml respectively [183]. However, other DPPH assay done on the stem and root 
extract of S. hispidus did not give a positive outcomes [185]. 
Lippia multiflora  
Description: Lippia multiflora belongs to the family Verbenaceae and generally 
found in tropical West Africa. Commonly called Gambia tea bush and also known 
locally as Afodoti, nyona (Ewe), Saresonunum, saanunum (Twi), Ngaa suru, Naa 
suru (Ga). A robust woody pubescent herby shrub up to 3 m high, bluish green leaves 
white or lilac fragrant flowers which are small and whitish with large oblong-
lanceolate bluish-green leaves [97]. 
Traditional Uses: Aqueous leaf extract are used to treat gastrointestinal problems, 
high blood pressure, as a diuretic, muscle relaxant [186] and analgesic [187]. The 
roots are used to treat malaria and for placental retention [4]. 
Antimicrobial Activity: Leaf extract of L. multiflora and its isolated compound 
carvacrol exhibited activity on Salmonella species, E. coli, S. aureus and B. subtilis. 
C. albicans had the highest inhibition zone for both hexane extract (24mm) at 
200mg/ml and carvacrol (38mm) at 4µl/disc [188]. The essential oil of the leaves had 
inhibitory effects on S. aureus (MIC 1.2 ± 0.1mg/ml), S. enterica (MIC 4.4 ± 
0.1mg/ml) among others [189]. Reference [190] also reported some antimicrobial 
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activity of the essential oil. Whilst the methanol extract of the leaves had activity on 
S. aureus, B. subtilis and E.coli, it did not show any antiviral activity when tested on 
herpes simples virus, sindbis and poliovirus. Similarly, the steam distilled volatile oil 
of the leaves also did not exhibit any antimicrobial activity (MIC 1250µg/ml) on the 
bacteria strains [191]. The leaves have been found earlier, to be active against 
isolated microorganisms of the buccal flora. Mouthwash prepared from the extract at 
1/500 dilution of essential oil was also active [192]. 
Anti-parasitic Activity: L. multiflora leave extract administered at 400mg/kg dose 
to adult albino rats infected with Trypanosoma brucei brucei did not show any 
reduction in the level of parasitaemia [193]. 
Pharmacological Studies: The essential oil of the plant with monoterpenes as major 
constituent is reported to have analgesic and antipyretic activities. The effect of the 
oil (2, 4, 8 ml/kg) on acetic acid-induced writhings in Swiss mice (20-25g) showed a 
dose-dependent analgesic activity. The oil also exhibited antipyretic activity in 
brewer’s yeast-induced hyperexic rats at the highest dose of 8 ml/kg; it however had 
no anti-inflammatory activity [187]. 
Genotoxicity and Cytotoxicity Studies: Continues exposure of Vero cells (Monkey 
kidney cell line) grown in Modified Eagle medium containing 5% foetal bovin serum 
to methanol leaf extract for 5 days showed cytotoxic effects at 125µg/ml [191]. 
Ashidi et al., 2010 [194] reported a moderate non-selective cytotoxicity of the plant 
on human breast adenocarcinoma cell line MCF-7, human large cell lung carcinoma 
cell line COR L23 and human amelanotic melanoma C32. The stem-back of the plant 
has also been found to be also cytotoxic [195].  
Khaya senegalensis  
Description:  Khaya senegalensis belongs to the family Meliaceae. It is a large tree 
that grows mainly in higher rainfall savannah woodlands and is native to Africa but 
can be found in Australia, Cuba and parts of Asia ([97], [116]). Commonly called 
mahogany, African mahogany other local names are Madwach (Hausa), Logo (Ewe), 
Okum (Fanti), Kuntunkuri (Twi). K. senegalensis is a deciduous evergreen tree up to 
30(–35) m tall with a grey to dark grey or greyish brown bark surface. The leaves are 
arranged spirally but clustered near ends of branches. The flowers are unisexual, 
male and female flowers very similar in appearance, regular, and whitish [196]. 
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Traditional Uses: K. senegalensis is used as a bitter tonic, as remedy for fever, 
vermifuge and for treating veneral diseases [41]. It is also used in treating malaria, as 
anthelmintic and mucus-containing diarrhoea [197]. Extracts of the stem-bark is also 
used for convulsion, hemorrhoids, heat rash, boils and arthritis [4]. 
Phytochemical Constituents: Saponins, tannins, phenols, alkaloids, cardiac 
glycosides and anthraquinones ([198], [199]). 
Antimicrobial Activity: The methanol and aqueous extracts of K. senegalensis 
leaves have been reported to show antimicrobial activity against both gram-negative 
and positive-bacteria as well as C. albicans [199]. The ethanol extract of the stem-
bark was highly active against E.coli and S. typhi at 20mg/ml [200]. Extracts of both 
leaf and bark also had some activity against S. aureus and Enterobactor species 
[201]. The root extracts has been reported to be active against P. aeruginosa, B. 
subtilis, C. albicans and S. aureus [202]. Limonoid compounds isolated from the 
leaves and twigs are reported to be active against MRSA and P. aeruginosa (MIC 
value of 12.5µg/ml) and antibacterial strains ([203] [204], [205], [198]). However, 
both aqueous and methanol extracts of the leaves did not show any activity when 
tested on bacterial isolates from post-surgical wounds [206]. The limonoid 
compounds of the plant had antifungal activity on Botrytis cinerea. It inhibited 
mycelia growth (60.83 to 68.33%) at 1000 to 1500ppm [207], the compound was 
also active against groundnut rust Puccinia arachidis [208]. 
Anti-parasitic Activity: Methanol extract from the bark of K. senegalensis had anti-
parasitic activity (IC50 9.8µg/ml) when tested on Leishmania donovani [204]. The 
methanol extract at 4, 2 and 0.4mg/ml had trypanocidal activity on T. brucei brucei 
and T. congolenses, causing complete cessation of motility of the parasites within 60 
minutes [209]. Various extracts of the plant tested for larvicidal activity on Culex 
annulirostries were active with LC50 ranging between 5.1 to 20.12mg/ml [210]. Two 
compounds, Catechin-(4α, 6)-catechin and Catechin-(4α, 8)-catechin isolated from 
methanol extract of the plant were tested on L. donovani, L. major and L. infantum 
promastigotes and amastigotes. The compounds did not show activity against the 
promastigotes (EC50 >50µg/ml), however, both were active on the amastigotes with 
EC50 of 3.85 and 3.98µg/ml [211]. 
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Pharmacological Studies: The effect of methanol bark extract of K. senegalensis on 
the cardiovascular system has been studied in rats. The extract at 1mg/ml was 
administered to urethane anesthetized rats with resting arterial blood pressure of 
122±3mmHg, there was an increase (p<0.001) of blood pressure to 145.4mmHg 
[212]. The plant extract at concentration lower and above 1x10-5 g/ml induced a 
dose-dependent relaxation and contraction of the smooth muscle of rat bladder [213]. 
The stem-bark exhibited anti-inflammatory effects by inhibiting croton-induced mice 
ear oedema. At a dose of 150µg/ear, the chloroform extract inhibited the oedema by 
70% compared with that of petroleum ether of 49% [214]. Administration of ethanol 
extract to rats at 2mg/kg body weight over a prolonged period of time (18 days) had 
a deleterious effect on the rat kidney [215]. The stem-bark, leaves and root have also 
been reported to have high antioxidant/free radical scavenging activity. The plant 
extracts exhibited radical scavenging potential with IC50 values of 178µl (leaves), 
91µl (stem-bark) and 122µl (root). The IC50 values on the hypoxanthine/xanthine 
antioxidant assay for leaves, stem-bark and roots were 46, 37 and 64 respectively 
[216].  
Cytotoxicity Studies: Catechin-(4α, 6)-Catechin and Catechin-(4α, 8)-Catechin 
tested on non-infective mammalian cell lines (RAW macrophages, squamous 
carcinoma (KB) and lung carcinoma A549) showed a non-toxic effect on the cell 
lines with effective doses (EC50) of up to 25µg/ml [211]. The effect of leaves and 
bark extract of K. senegalensis on oxidative burst of isolated polymorphonuclear 
cells (PMNs) and mononuclear cells (MNCs) has been reported by Koko et al., 2008 
[217].  Both extracts at 6.25µg/ml had some inhibitory effects (70.7, 67.1, 69.5 and 
67.4%) on both phagocytes. Limonoid compound, 3α, 7α-dideacetylkhivorin from 
methanolic extract was found to have significant growth inhibitory (anticancer) 
activity on MCF-7, SiHa and Caco-2 cell lines with IC50 of 0.07-0.14µM [218]. 
Kigelia Africana 
Description:  Kigelia Africana belongs to the family Bignoniaceae and is found 
across the African continent, with wide distribution in South, Central and West 
Africa. It spreads across riverside and wet savannah areas [219]. Commonly called 
sausage tree and known locally as Nufuten (Asante), Nyakpekpe (Ewe), Teeleo (Ga), 
Etua (Fante). It is a medium-sized, semi-deciduous tree which measures up to 25m 
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high. The bark is grey, smooth and flaky. Its leaves are opposite or whorled. The 
flowers are bisexual and very large with large sausage-like fruits [220]. 
Traditional Uses: The stem bark is also used to treat venereal diseases, epilepsy, 
wounds and oedema. The fruit and roots are used for the treatment of elephantiasis, 
snake bite, hemorrhoids, tapeworm infestation ([221], [4]). 
Phytochemical Constituents: Presence of alkaloids, flavonoids, tannins, reducing 
sugars, saponins, glycosides and anthracene derivatives ([222], [223]). 
Antimicrobial Activity: The ethanolic extract of the stem bark was active against S. 
aureus and C. albicans [222]. Antibacterial activity of hexane stem bark extract 
against B. cereus has also been reported [224]. Methanolic extract of the leaves and 
stem bark were active against E. coli, P. aeruginosa, B. subtilis, S. aureus and C. 
albicans, MIC ranged between 2.25 to 7.5mg/ml [182]. Other antimicrobial activity 
has been reported by Jeyachandran and Mahesh, 2007 [225]. 
Anti-parasitic activity: Leaf extract at 2mg/ml was active against nematode 
Caenorhabditis elegans and enteropathogenic Entamoeba histolytica [226]. The root 
and bark extracts of the plant exhibited a weak antitrypanosomal (IC50 -22µg/ml) and 
anti-plasmodial (IC50 > 5µg/ml) activity against T. brucei rhodesiense and P. 
falciparum [227]. 
Pharmacological Studies: Antidiarrheal activity of the aqueous extract on castor oil-
induced diarrhea in adult male Wister rats has been reported by Akah, 1996 [223]. 
Results showed a significant (p<0.01) reduced fecal output. The extract also blocked 
(p<0.01) nicotine-induced contractions in the Guinea pig ileum activity test. Both 
leaf and stem-bark showed a low free radical scavenging activity (IC50 13.7, stem-
bark and 56.9µg/ml, leaves) in a DPPH assay. Wound treated with the extract 
showed significant healing from the 10th to 18th day [182]. Analgesic property of the 
plant has also been studied using acetic acid-induced mouse writhing as well as hot 
plate reaction time. In this study, there was a significant (p<0.001) inhibition of the 
writhes, however, the hot plate reaction time did not change. Extract of the plant is 
also reported to have reduced significantly (p<0.05), the production of thiobarbituric 
acid reactive substances (TBARS) induced by pro-oxidants in rat liver homogenate 
[228]. The leaf extract (100mg/kg) was again reported to possess hepatoprotective 
properties against acetaminophen-induced toxicity in mice [229]. The fruit is also 
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reported to have protective property against Cisplatin-induced toxicity in male rats 
[230]. 
Cytotoxicity and Genotoxicity Studies: The fruit extract of K. Africana tested 
negative for Salmonella typhimurium strains TA98 and TA100 in a mutagenicity test 
(without metabolic activation), whiles the same extract showed moderate 
cytotoxicity activity in a brine shrimp nauphlii bioassay [221].  The extract again 
gave negative results for strains TA98 and TA100 in a similar genotoxicity test by 
[231]. Kigelia. africana seed oil is also reported to have suppressed proliferation of 
Caca-2cell [232], and [219] reported n-hexane extract of two of its compounds were 
cytotoxic at higher concentrations. 
Mitragyna stipulosa(DC.) Kuntze 
Description:  Mitragyna stipulosa belongs to the family Rubiaceae. It is widely 
distributed across West Africa, in swamps and marshy localities. Commonly called 
African linden and locally known as Baya,-Subaha (Nzema), Supaya, Supaha-akoa 
(Asante). It is a medium size to fairly large tree of up to 35m tall. The bark is smooth 
to irregularly thin scaly or longitudinally fissured. The leaves are opposite, simple; 
stipules obovate to nearly round, up to 8 cm x 5 cm, hairy in lower parts. Flowers are 
bisexual, regular and scented. [233]. 
Traditional Uses: Mitragyna stipulosa is used mainly to treat malaria, diarrhoea, 
muscle pain, hypertension and for inflammation [234]. The stem-bark is used for 
female infertility treatment, skin ulcer and the leaves for wound healing [4]. 
Phytochemical constituents: The plant has been found to contain saponins and 
tanins [235]. 
Antimicrobial Activity: Mitragyna stipulosa bark extract exhibited antidiarrhoeal 
properties by showing activity against different strains of E. coli [235] and Vibrio 
cholerae [236]. 
Pharmacology and Cytotoxicity Studies: Two compounds, triterpenoids made up 
mainly of quinovic acid and glycoside derivative had inhibitory effects against snake 
venom phosphodiesterase with IC50 values of 0.166± 0.013 and 0.374± 0.009mM 
respectively [237]. Triterpene derivative compounds isolated from M. stipulosa 
showed varying levels of cytotoxicity in an MTT assay with ursolic acid being the 
most active compound [238]. 
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Chlorophora excelsa (Welw) Benth 
Description:  Chlorophora excelsa belongs to the family Moraceae. It is native to 
Africa, widely distributed across tropical Africa and commonly called African teak 
or locally Odoum (Akan). It is a large tree which measures up to about 60m in 
height, with a dark colour with shades ranging from brownish yellow to green [239]. 
Traditional uses: Extracts from parts of the plant is used to treat cough associated 
with bronchitis, as an antibacterial, for lumbago, fever and rheumatism ([240], [41]). 
The stem bark is used as anti-inflammatory agent [241]. 
Phytochemical Constituents: Carbohydrate, tannins, glycosides, saponins, sterols, 
resins, flavonoids and alkaloids according to Abulude, 2007 [242]. 
Antimicrobial and Anti-parasitic Activity: Phenolic compounds, chlorophin and 
iroko isolated from aqueous extract of C. excelsa actively inhibited B. coagularis and 
S. pneumoniae at 1.95µg/ml (chlorophorin) and 3.125, 6.25µg/ml (iroko). The 
extracts were also active against fungal isolates F. verticilloides and A. flavus . 
Chlorophin and iroko also showed anti-parasitic activity against E. histolytica 
trophozoites with MIC of 0.25(chlorophin) and 1µg/ml (iroko) [243]. 
Pharmacological Studies: The stem-bark extract has been reported to have shown 
anti-inflammatory activity by significantly (p<0.05) as shown by inhibition of 
carrageenan-induced rat paw oedema, in a cotton pellet granuloma formation test in 
rats [239].  It reduced cotton pellet dry weight (p<0.05) at all concentrations and also 
inhibited ear oedema in mice at 400mg/kg after application of croton oil. Chlorophin 
has also been reported to possess antioxidant activity. The compound regulated 
unstabilised Hercules Ester gum 8D-LT and dipentene [244]. 
Genotoxicty and Cytotoxicity Studies: Chlorophorin was found to be non-
mutagenic whilst C. excelsa was slightly mutagenic for the Salmonella typhimurium 
strain TA97. Both extracts showed no cytopathic effect on cell lines in an MTT assay 
[243]. 
Monodora myristica  
Description:  Monodora myristica belongs to the family Annonaceae. It is native to 
tropical West Africa, Uganda, Kenya and Tanzania. It is commonly called calabash 
nutmeg and locally known as Ayerew (Fante), Avoncoba (Nzema), Awerewa (Twi) 
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and Yikwi (Ewe). M. myristica is a branching tree of about 35m high. The leaves are 
large, about 35cm long and 18cm wide. The flowers are scented and waxy, with large 
woody fruits which are filled with brown seeds in a pulp ([94], [245]). 
Traditional Uses: The seeds are used for anaemia, haemorrhoid, sexual weekness, 
wounds, numbness and drancontiasis, the roots for arthritis [4]. It is also used 
stomach ache, hypertension [246], malaria and constipation [247]. 
Phytochemical Constituents: Tannins, glycosides, flavonoids, steroids, cyanogenic 
glycosides ([248], [249). 
Antimicrobial Activity: The essential oil of the fruit had antibacterial activity on a 
range of microorganisms. It also had antifungal activity against A. flavus [250]. The 
fresh seed and essential oils also had activity against B. subtilis, C. albicans and S. 
aureus and other clinical isolates ([251], [248]). The dried seed essential oil was 
moderately active on mycotoxin producing fungi, Fusarium moniliforne, A. flavus 
and A. fumigatus at 500ppm [252]. Aderotimi, 2009 [253] reported a similar 
antifungal activity of the seed extract on F. nivale, R. stolonifer and A. fumigatus, 
fungi isolated from spoilt sweet potatoes. The ethyl acetate extract had a higher 
inhibition (9.5 ± 0.01 to 13.5 ± 0.1 mg/20ml) of fungal growth. Organic and aqueous 
seed extract at 200, 100 and 50mg/ml were active against selected bacterial strains 
and C. albicans with the organic extract showing a better activity (MIC 12.5 to 
100mg/ml) on most strains [254]. Cyclohexane and ethyl acetate extract of fruit had 
good inhibitory effect on C. albicans and C. krusei (MIC 6.3 - 12.5µg/ml) ([255], 
[256]). 
Anti-parasitic Activity: Crude extracts of M. myristica stem bark exhibited anti-
helminthic activity (EC50 2.5µg/ml) and anti-scabies activity (EC50 2250mg/ml2) 
against nematode and mites. However, the extract was not active against P. 
falciparium and T. brucei brucei [257]. Both methanol and dichloromethane extracts 
of the plant were active against two chloroquine resistant strains of P. falciparum 
(FCB and W2). The methanol extract had a higher activity (IC50 5.5 ± 2.0 and 6.1 ± 
1.5µg/ml) as compared to that of dichloromethane (IC50 ± 4.3 and 28.1 ± 1.5µg/ml) 
against FCB and W2 strains of P. falciparium [247]. 
Pharmacological Studies: The essential oil of the leaves exhibited a weak anti-
inflammatory effect on soybean lipoxygenase activity at 10pm (28 ± 0.7%) and a 
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weak antioxidant activity (SC50 15.0 ± 0.8g/L) in the DPPH assay [258]. 
Hypotensive effect of the seed extract has been reported by Koudou et al., 2007 
[246]. At dose range of 40, 80 and 12µL kg-1, the oil reduced the blood pressure of 
guinea pig in a dose-dependent manner. The oil also caused a reduction in heart 
contraction of frog. The ethanol and aqueous extracts of the seed showed a strong 
antioxidant activity with the ethanol extract being more active than the aqueous 
extract. The extracts significantly (p<0.05) caused reduction in DPPH radicals, 
reduced effect on Fe3+ and chelated Fe2+. It was also protective against hydroxyl 
radicals and inhibited lipid peroxidation [259]. Similar antioxidant activity of the 
seeds has been reported by Uyoh et al., 2013 [260]. The extract had 37.37 ± % mean 
scavenging power and a hydroxyl radical scavenging power of 17.10 ± 1.345%. It 
also had a reducing power of 0.074 ± 0.001nm and a total antioxidant capacity 
(TAC) of 0.198 ± 0.02nm. 
 Cytotoxicity Studies: The methanol and dichloromethane extracts of the plant has 
been reported to exhibit cytotoxic effects on MRC-5 human diploid embryonic lung 
cell [247], it was also found to be cytotoxic on Human pancreatic cell lines [261]. 
Alchornia cordifolia  
 Description: Alchornia cordifolia belongs to the family Euphorbiaceae. It is 
distributed across Senegal east to Kenya and Tanzania, across Central Africa to West 
Africa. It is commonly called Christmas bush and locally known as  Agyama (Twi), 
Gboo (Ga-Adamgbe), Avovlo(Ewe), Bambamie (Hausa). It is a straggling shrub or 
small tree of up to 8m tall. The leaves alternate, simple; stipules triangular and 
1.5mm long. The flowers are unisexual, seeds ovoid, ellipsoid, smooth and bright 
red. The fruits are 2-lobbed capsule ([159], [262]). 
Traditional Uses: The leaves are used for treating cough, bronchitis, malaria, 
headache, angina, dysentery and intestinal parasites [263] wounds, ringworm, yaws, 
abdominal pain, herpes zoster, dermatitis, jaundice, anaemia and dysmenorrhea. The 
roots are used for treatment of septicaemia, whooping cough and stomatitis [4]. It is 
also used for female infertility, peptic ulcer, as a purgative and for inflammation 
[262]. 
Phytochemical Constituents: Flavonoids, tannins, steroid, terpens, saponins and 
alkaloids [264]. 
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Antimicrobial and Anti-parasitic Activity: Compounds isolated from methanolic 
leaf extract were active at 50mg/ml against S. aureus (16-28mm) and E. coli (12.5-
19mm). Various fractions of isolated compounds at 100mg/ml were also active 
against S. aureus, E. coli, B. subtilis and P. aeruginosa [265]. In another study, the 
methanolic leaf extract was also active on S. aureus and C. albicans [266]. Aqueous 
extract of leaf extract tested against a wide range of clinical and environmental 
microorganisms at 5mg/ml inhibited 36.5% of isolates. The inhibition rate was 
95.9% at 20mg/ml with most activity being against gram positive organisms and 
yeast [267]. Crude extract of the root bark is reported to exhibit anti-amoebic activity 
on clinically isolated E. histolytica strain (MIC of 62.5µg/ml) [264]. 
Pharmacological Studies: The ethanol leaf extract exhibited antidiarrheal activity 
on castor oil-induced diarrhea in mice. The extract in a dose dependent manner, 
reduced the frequency of diarrhea with 64.6% inhibition at 800mg/ml [268]. 
Fractions of leaf extract have been reported to have anti-inflammatory effect in egg 
albumin-induced rat hind paw oedema. The aqueous methanol extract showed a 
significant (p<0.05) 68.25% inhibition at 50mg/kg. Other fractions also showed 
activity at 100mg/ml with one fraction (A2) which had the highest activity of 50% 
inhibition also showing significant (p<0.05) analgesic activity [269]. Other anti-
inflammatory activity of the methanol leaf extract has been reported by Manga et al., 
2004 [262]. Fractions of the extract reduced croton oil-induced ear oedema in mice, 
with the hexane fraction having a higher inhibitory effect of 42% at 0.7µg/cm2. The 
aqueous root extract at 100-400mg/kg significantly (p<0.05) inhibited writhing 
reflex, neurogenic and inflammatory pains in mice ([105]. 
In a toxicity study by Ansah et al., 2011 [270], the ethanol extract administered to 
rats at 250 and 500mg/kg did not exhibit any toxic effect. However, at higher doses 
(1000, 2000mg/kg), there were signs of hepatotoxicity in the rats. The seeds are also 
reported to be toxic when fed to broiler chicks [271].The plant is reported to have 
showed antioxidant activity by reducing DPPH free radical and also had protective 
effect against carbon tetrachloride-induced liver damage in rats [272].The effect of 
aqueous leaf extract on anxiolytic activity in mice using spontaneous movements and 
exploratory behavior was studied by Kamenan et al., 2013 [273]. The extract at 
2500mg/kg showed a depressing effect on the central nervous system by reducing all 
spontaneous movement in mice. The plant at a minimum dose of 200mg/kg 
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significantly (p<0.05) decreased the blood glucose levels of streptozotocin-induced 
diabetic rats, it also increased the levels of some haematological parameters (red cell 
count, haemoglobin concentration, total white cell count and lymphocytes) [274].  
Genotoxicity and Sytotoxicity Studies: Alchornia. cordifolia gave negative results 
in a genotoxicity study by [115]. The extract tested negative against the Salmonella 
typhimurium strains TA98, TA100, TA1535 and TA1537, and Escherichia coli 
WP2uvrA. Flavonoid-rich fractions from the plant have also been cited as having 
strong immunomodulatory activity [275], and the leaf extract has been reported to be 
non-cytotoxic ([276], [263). 
Terminalia ivorensis 
Description:  Terminalia ivorensis belongs to the family Combretaceae and is native 
to tropical West Africa, but can also be found in South America, Fiji and the 
Solomon Island [277]. It is common called black Afara and locally as Dzogbedodo 
(Ewe), Emire (Twi). It is a large deciduous forest tree between 15 to 46m tall. There 
are no branches up to 30m, and the mature trees are very flat topped with wide 
canopy horizontally. The branches of the young trees are whorled and the back flakes 
off in long thin strips. The leaves are simple, whorled, oval and blunt tipped with 
orange-brown hairs below and on veins above ([277], [278]). 
Traditional Uses: Terminalia. ivorensis is used to treat arthritis, syphilis and as a 
diuretic ([279]. The stem bark is also used for wound healing and rheumatism [97]. 
Phytochemical Constituents: Saponins, tannins, flavonoids and alkaloids [280]. 
Antimicrobial and Anti-parasitic Activities: The aqueous and hydro-alcoholic bark 
extract had antifungal activity against C. albicans and A. fumigatus. The 
hydroalcoholic extract exhibited a high activity with minimal fungicidal 
concentration of 97.5µg/ml for both organisms and an IC50 0f 11.40µg/ml (C. 
albicans) and 5.16µg/ml (A. fumigatus) [281]. The crude, chloroform and aqueous 
fractions were active against S. aureus, E. coli and S. pneumonia (MIC of 22.15 to 
7937.04µg/ml) [282]. Ethyl acetate, ethenolic extract and their fractions exhibited 
antitrypanosomal activity against T. brucei rhodensiense [283]. Ethenolic stem bark 
extract of T. ivorensis at 25µg/ml showed an 83.34% inhibition against chloroquine 
resistant strains of P. falciparum with IC50 of 6.95µg/ml [280]. 
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Pharmacological and Cytotoxicity Studies: Patients suffering from arthritis who 
were treated with bark extracts of T. ivorensis showed a remarkable improvement in 
their conditions and the  extract at 100-300mg/kg also decreased carrageenan-
induced rat paw oedema and delayed castor oil-induced diarrhea [284]. Compounds 
isolated from the bark (ivorensis B and C) had DPPH and ABTS radical scavenging 
activities. Ivorensis A exhibited anti-proliferative activity against MDA-MB-231 and 
HC7116 human cancer cell lines (IC50 of 3.96 and 3.43µM) [285]. Crude, 
chloroform and aqueous extracts of the bark are also reported by Cobbinah, 2008 
[282] to have antioxidant activity by exhibiting significant reducing power and 
decomposition of hydrogen peroxide. 
Clausena anisata   
Description: Clausena anisata belongs to the family Rutaceae. It occurs in Savanna, 
Riverine forest, and Secondary forest. It is distributed in tropical Africa, tropical Asia 
and South-East Asia. Commonly called horsewood or maggot killer. It is also known 
locally as Ayida, Ayra (Ewe), Samanyobli (Ga), Sesadua, Samanobere (Twi), 
Sesabaka (Nzema). Clausena anisata is a deciduous shrub or small tree of about 4m 
tall. The bark is smooth and leaves about 30cm long. The flowers are bisexual and 
irregular [286]. 
Traditional Uses: C. anisata is used for the treatment of fungal infection of the skin 
and oral candidiasis [287]. It is also used for epilepsy, anticonvulsant [288], for high 
blood pressure and as a mosquitoe repellent [289]. The roots and bark are also used 
for intestinal helminthiasis, dysentery, toothache, arthritis, herpes zoster, 
rheumatism, fracture and abdominal pains [4]. 
Phytochemical Constituents: Cardiac glycosides, tannins, saponins, terpenes and 
flavonoids [290]. 
Antimicrobial Activity: Two carbazole alkaloids, clausenol and clausenin isolated 
from the stem bark showed activity against both bacterial and fungal isolates [291]. 
C. anisata aqueous leaf extract showed moderate inhibitory effect on HIV-1 with 
EC50 of 0.70mg/ml and 50% cytotoxic concentration (CC50 ) of >1.4mg/ml [292]. 
The methanolic extract of the aerial parts of the plant at 1000-2000µg/ml had activity 
against N. gonorrhoeae [293], and the stem bark extract exhibited a strong antifungal 
activity against C. neoformans, C. tropicalis, C. krusei and C. parapsilosis [287]. 
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The essential oil of the leaf extract, estragole-rich oil and trans-anethole-rich oil 
showed antimicrobial activity against both fungal and bacterial clinical isolates 
[294]. The essential oil of the leaves also showed activity against S. typhimurium and 
P. aeruginosa with MIC values of 62.5 and125 µg/ml [295]. Similar antimicrobial 
activity of the essential oil has been reported by Guandidza et al., 1994 and Van 
Vuuren et al., 2006 [296] and [297]. 
Anti-parasitic Activity: The ethanolic and aqueous leaf extract of the plant showed 
anthelmintic activity inhibiting Caenorhabditis elagans [226]. The crude extract (39-
1117mg/kg), chloroform and aqueous fractions (78mg/kg) of leaf extract 
significantly (p<0.001) reduced the level of parasitaemia in mice infected with 
chloroquine resistant P. berghei [290]. 
Pharmacological Studies: Methanolic root extract at 100-800mg/kg administered to 
normal and streptozotocin induced diabetic rats produced significant (p<0.05-0.001) 
dose-dependent hypoglycaemia [298]. The crude extract, chloroform and aqueous 
fractions significantly (p<0.001) inhibited inflammation in mice by reducing acetic 
acid-induced writhing, formalin-induced hind paw licking and delayed hot plate pain 
reaction [290]. 
Genotoxicity and Cytotoxicity Studies: Imperatorin, isolated from C. anisata was 
found to be mutagenic using Salmonella typhimurium strains TA97, TA 98 and 
TA100 in Ames test [299]. However, alkaloid isolates from the plant have been 
reported to have antitumor promoting activity [300].  
Piliostigma thonningii   
Description:  Piliostigma thonningii belongs to the family Fabaceae. It is found in 
wooded grassland and woodland in Sub-humid Africa and Asia. Commonly known 
as camel’s foot or monkey bread, and locally called Opitipata, Tofotafa (Twi), 
Nyanga (Mole), Klo (Ewe). It is a single stem deciduous tree which measures about 
4-15m long. The bark is rough with leathery green leaves of 15x17cm. The flowers 
are unisexual, but both male and female are usually on separate trees. Its pods which 
are indehiscent, measures up to 26x7cm and persist on the tree but finally fall and 
decay to pea-sized seeds ([301], [302]). 
Traditional Uses: The roots and twigs are used to treat hookworm infestation, skin 
infections, dysentery, fever, respiratory ailments and snake bites [303]. Extracts from 
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the leaf are also used for malaria [304]. The leafy stem is used for pruritus, the stalk 
for chicken pox [4]. 
Phytochemical Constituents: Saponins, flavonoids, phenolics, glycosides, 
anthraquinones and cardiac glycosides [303]. 
Antimicrobial and Anti-parasitic Activity: Methanol extract of the stem bark at 
20mg/ml had antibacterial activity against selected organisms (zone of inhibition of 
10-17mm) including S. pyogenes and S. dysenteriae had a higher activity with MIC 
values of 0.313mg/ml for both organisms [305]. C-methylflavonol compounds 
isolated from the leaves were active against S. aureus whiles ethanolic extracts had 
activity against other selected bacteria strains [306]. P. thonningii exhibited toxic 
effects on L3 infected stage of Haemonchus contortus. It also had inhibitory effect 
on Ascaris (IC50 2, 10 and 15µg/ml) and Onchocerca (IC50 4, 8 and 28µg/ml). The 
extract at 100ppm also killed 50% of brine shrimp nauplii [307]. 
Pharmacological Studies: The aqueous and ethanol leaf extract of P. thonningii 
produced haemostatic effect on isolated aortic rat rings. The extract at 32mg/ml gave 
a better contractile response of 30.8%±1.6% of that produced by 1µM phenylephrine, 
whilst the ethanol extract at 64mg/ml produced 12.3%±0.9% contractile response. 
The aqueous extract also significantly (p<0.05) reduced bleeding time [308]. When 
administered to rats (200-400mg/kg) over 21 day period, it produced significant 
(p<0.05) decrease in haematological parameters (red blood cells, white blood cells, 
lymphocytes and neutrophils) and biochemical indices inferring that the plant might 
have possible effect on kidney function [309]. Aqueous extract at 0.2g/kg 
significantly (p<0.05) decreased the levels of serum lipids from 112.85±1.5 to 
91.76±3.6mg/dl (Total cholesterol), 104.24±4.5 to 82.91±3.1mg/dl (Triglycerides) 
and 46.19±2.0 to 36.76±2.4mg/dl (LDL Cholesterol) [310]. 
 The methanol leaf extract at 50, 100 and 200mg/kg, showed antiulcer effect in vivo 
in rats by reducing (57.1, 65.7 and 80% ulcer inhibition) indomethacin-induced 
gastric ulcer [311]. C-methylflavonols compounds isolated from the leaves, as well 
as crude and ethanol extracts have earlier been reported to have anti-inflammatory 
properties [307]. Ethyl acetate leaf extract exhibited hepatoprotective activity against 
toxicity induced by aluminium chloride [312]. Similar hepatoprotective activity of 
the leaves has been reported by [313]. In his study, the extracts at 50, 100 and 
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200mg/kg administered for 14 days to rats had protective effect acting as a free 
radical scavenger against carbon tetrachloride-induced hepatic and oxidative damage 
in the rats. A brine shrimp lethality assay also showed the plant was relatively non-
toxic [314]. 
Trichilia monadelpha  
Description: Trichilia monadelpha is a member of the family Meliaceae. It is found 
in lowland high forest, often on river banks in parts of Africa and is known locally as 
Otanduro (Twi), Tenuba (Nzema). It is a small to medium sized tree of about 12-20m 
high [97]. 
Traditional Uses: The aqueous roots are used for treating diarrhoea and dysentery, 
the bark and roots as depressants, for arthritis, rheumatism, yaws and as abortifacient 
It is also used for subcutaneous parasitic infection, epilepsy and inflammation ([97], 
[116]). 
Pharmacological Studies: Extracts of the stem bark of T. monadelpha exhibited 
antioxidant activity in a DPPH scavenging and reducing power test. Ethanolic and 
ethyl acetate extracts showed a stronger reducing activities (EC50 values of 0.87±0.11 
and 13.63±0.38mg/ml) compared to that of petroleum ether (EC50 
81.06±4.35mg/ml). All extracts had free radical scavenging activities [315]. The 
stem-bark extracts were also reported to reduce acetic acid-induced abdominal 
writhings in mice, increased paw withdrawal thresholds (maximum effect at 
300mg/kg) in carrageenan-induced mechanical hyperalgesia test in rats and also 
significantly (p<0.0001) inhibited neurogenic and inflammatory effects on right hind 
paw in mice with 5% formalin [316]. Trichilia. monadelpha aqueous and petroleum 
ether extract inhibited carrageenan-induced foot-oedema (57.79±3.92 and 63.83±1.2) 
in chicks. The aqueous, petroleum ether as well as ethanol extracts also had 
inhibitory effects on inflammation associated with adjuvant-induced arthritis in rats 
[317]. Extracts of the plant are also reported to demonstrate excision wound healing 
properties and also showed dose dependent antimicrobial effects on intestinal 
microflora in colitic rats [318]. Aqueous root extract administered to male albino rats 
at 400mg/kg/day for 4 weeks had significant (p<0.01) increase in sperm motility 
(from 5.75±0.38% to 11.86±0.70%) and viability (from 13.3±1.16% to 19.9±2.45%). 
It also showed a decrease in testosterone level [319]. 
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Mussaenda erythrophylla 
Description:  Mussaenda erythrophylla belongs to the family Rubiaceae. It is native 
to Western tropical Africa and also seen as ornamental plant in India [320]. It is 
commonly called Ashanti blood or Red flag and known locally as Damarama, 
Akoko-ninidame (Asante), Akokonyindam (Fante). It is a climbing shrub of about 
12m high with broad leaves, flowers are cream yellow or orange in appearance with 
an enlarges sepal (calyx) pink or red [4]. 
Traditional Uses: Musseanda erythrophylla is used traditionally for cough, diuretic, 
jaundice and as an appetizer [321]. It is also used to treat acute gastroenteritis, 
dysentery and laryngopharyngitis [322]. 
Phytochemical Constituents: Flavonoids, steroids, glycosides, triterpens, saponins 
and tannins ([321], [322]). 
Anti-parasitic Activity: The ethyl acetate and methanol extract of the roots at 10, 
20, 40 and 80mg/kg exhibited significant (p<o.01) anthelmintic activity against 
Pheretima posthuma by causing paralysis and death of the worm. The ethyl acetate 
extract gave a shorter death time at 93±8.40mins compared to that of the methanol 
extract of 128±5.22mins [323].  
Pharmacological Studies: The ethyl acetate and methanol stem extracts of the plant 
has been reported to be hepatoprotective in a carbon tetrachloride-induced 
hepatotoxicity test in rats. It has exhibited superoxide radical scavenging, lipid 
peroxidation inhibition, DPPH radical scavenging and hydroxyl radical scavenging 
activities [321]. Chloroform and ethanol extract are also reported to have diuretic 
effects in normal rats. The extracts, at 250 and 500mg/kg, increased urine volume, 
excretion of sodium and potassium. The extracts did not produce any toxic effects in 
mice when administered up to 2000mg/kg extract [322]. 
Anthocleista nobilis  
Description: Anthocleista nobilis belongs to the family Loganiaceae, It is distributed 
in the tropical rainforest mainly in West Africa [324].  Cabbage tree or cabbage palm 
is the common name and the local name is Owudifo kete (Twi). It is small to medium 
–sized tree up to 18m tall. The bark is pale grey and smooth, leaves opposite and 
crowded at the end of branches. Flowers are bisexual and seeds obliquely ovoid-
globuse [324]. 
 40 
 
Traditional Uses: Aqueous extracts of the plant are used traditionally for dysentery, 
fever, gonorrhea, diarrhea and stomachache [325], [326]). It is used for the treatment 
of diabetes mellitus, abdominal pains and malaria [129]. 
Antimicrobial and Anti-parasitic Activity: The methanolic extract had moderate 
antimicrobial activity against selected organisms. Micrococcus flavus had a higher 
activity (MIC value of 32µg/ml) compared to those of B. subtilis, E. coli and 
resistant strains of S. aureus (MIC values >512µg/ml) [327]. The ethanol exteact of 
the root administered to T. brucei brucei infected mice did not reduce the level of 
parasitaemia [328]. The root extract at 0.5mg/100g is reported to have antiviral 
activity in Newcastle virus-infected fowls [329]. 
Pharmacological Studies: Ethanol root extract is reported to have a relaxation effect 
on guinea-pig ileum. The (67mg/kg) reduced pentobarbitone induced sleep time in 
chloroform poisoned mice. It also showed a dose-dependant toxic effect in mice with 
an LD50 of 200mg/kg [328]. The plant extract showed a DPPH scavenging activity 
(IC50 of 50.9µg/ml), 57% protection against hydrogen peroxide damage to fibroblast 
cells and also had in vivo wound healing effects on both excision and incision wound 
rat models [327].The plant has earlier been reported by Duwiejua, 1983 [330] to have 
hypotensive activity. 
Desmodium adscendens (Sw.) DC. 
Description: Desmodium adscendens belongs to the family Fabaceae. It is 
distributed across the Amazon rain forest of Peru, South America and West coast 
Africa [331]. It is locally known as Akwamfanu (Akan), Ananse, Nkatse (Fante), 
Azigbe, Anyigo (Ewe), Nkatenkate (Twi). It is a weedy perennial herb; multi 
branched and grows up to about 50cm tall. It produces numerous light purple flowers 
and small green fruits in 3cm long pods. 
Traditional Uses: Desmodium adscendens is used for the management of Asthma, 
diseases with smooth muscle contraction [332], dysmenorrhea, wounds, infantile 
diarrhea [4], gonorrhea, excessive urination, ovarian inflammations, diarrhea, fever, 
pain and epilepsy [333]. 
Phytochemical Constituents: Phenols, Flavonoids, anthocyanins and tannins [334]. 
Anti-parasitic activity: The aqueous, ethanol and pentane extracts of the whole 
plant tested against two chloroquine-resistant P. falciparium stranis; FCM29-
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Cameroon and another strain fron Nigeria showed a weak antiplasmodial activity. Of 
the three extracts, pentene had a better activity with IC50 values of 41-70µg/ml 
(Nigerian resistant strain) and 35µg/ml (FCM 29 strain) [335]. 
Pharmacological Studies: Desmodium adscendens extracts and fractions are 
reported to have shown anaphylactic activity on guinea-pig. Both aqueous and 
ethanol extracts reduced anaphylactic contraction of guinea-pig ileum at various 
concentrations. The extract was observed to have reduced sensitivity of the ileum to 
histamine-induced spasms ([336], [337]). The leaf fractions are also reported to have 
effect on contractions of respiratory smooth muscle and contractions induced by 
histamine, carbachol and leukotriene D4 [338]. Triterpenoid glycoside compounds 
isolated from the plant are reported to be potent activitors of calcium-dependent 
potassium channels in smooth muscle [339]. Pre-treatment of mice with the extract 
(100, 300mg/kg) reduced pentylenetetrazole-induced (85mg/kg) convulsion and 
mortality. The extract also delayed significantly, the latency and limbic seizures in 
kainic acid (12mg/kg) induced seizures in rats. However, at 50, 100 and 300mg/kg, 
the extract had a low suppression of writhing induced by acetic acid by 26.05, 45.5 
and 56.73% respectively [340]. The leaf extract at 25mg/ml is reported to reduce 
(83.21± 6.21%) reactive oxidative species generated by hydrogen peroxide. The 
extract also showed antioxidant activity in the ABTS (12.83mg) and DPPH (8.47mg) 
assays [336]. Reference [341] also reported similar antioxidant properties of 
flavonoid extracts of the plant. Another study on the antioxidant activity of the plant 
has been by [334]. 
Cytotoxicity Study: Extracts of the plant showed a weak cytotoxicity on A375 
melanoma cells with pentane showing a better activity with IC50 value of 70-90µg/ml 
[335]. Its immunoprotective property on both cellular and humoral immunity in mice 
has also been reported Rammal and Soulimani, 2011[342].  
Conclusion 
The role of medicinal plant products in the health care delivery system in Ghana and 
other developing countries cannot be over-emphasized. Various pharmacological, 
antimicrobial and cytotoxicity studies conducted by researches on these plants 
provide evidence and perhaps supports their use for various conditions claimed by 
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herbal medicine producers. However, more studies in relation to the longtime effects 
of using these medicinal products are needed to ascertain their safety. 
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1.3  List of Commonly Marketed Ghanaian Medicinal plant 
Formulations targeted for Investigation in this Project 
Table 2. Medicinal plant products with claimed therapeutic benefits 
Product Constituents Claimed therapeutic 
benefits 
E1 Nauclea latifolia, Phyllanthus fraternus, 
Cryptolepis sanguinolenta 
Malaria, Typhoid fever  
E2 Ocimum gratissimum, N. latifolia, C. 
sanguinolenta 
Typhoid fever 
E4  Cnestis ferruginea, Paullinia pinnata,  Cough  
E5 Momordica charantia Vernonia amagdalina,  
Strophanthus hispidus, Lippia multiflora 
Diabetes 
E6 Khaya senegalensis, Kigelia africana, 
Mitragyna stipulosa 
Aneamia/tonic  
E7 Monodora myristica, Chlorophora excelsa,  
Alchornea cordifolia, K. senegalensis 
Haemorrhoids (piles) 
E8 Clausena anisata, Pilostigma thonningii, 
Trichilia monadelpha, K. senegalensis, N. 
latifolia 
Arthritis 
E9 Anthoscleista nobilis, Mussaenda 
erythrophylla,  Vernonia amygdalina 
Candidiasis 
E10 Desmodium adscendens Asthma  
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1.4 Aims embodied in this MPhil Project 
 To screeen commonly marketed herbal medicinal products on the Ghanaian 
market for their mutagenic potential using the bacterial reverse mutation 
assay (Ames test) 
 To determine the antimicrobial properties of commonly marketed Ghanaian 
medicinal plant product formulations. 
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Chapter Two  
Materials And Methods 
2.1 Salmonella typhimurium Bacterial Reverse Mutation Assay 
(Ames test) 
2.1.1 Bacterial strains 
Salmonella typhimurium mutant strains (TA 98, TA 100, TA 1537) previously 
developed by Ames (1971), were obtained from the Microbiology Service Section, 
School of Biomedical Sciences, Curtin University. The S. typhimurium mutant 
strains were histidine dependent with either frameshift or base-pair substitution 
defects. 
2.1.2  Cultivation and Storage of Bacterial Strains 
The bacterial strains obtained were grown on Mueller Hinton (MH) agar by 
incubating the plates at 37ᴼC overnight. Several colonies from the overnight cultures 
were each inoculated in vials containing plastic beads immersed in cryopreservative 
fluid (Thermo Fisher, Australia). The vials were inverted about ten times for 
emulsification of the colonies. The cryopreservative fluids were then removed before 
storage of the bacterial strains at -80oC freezer. 
2.1.3  Validation of Salmonella typhimurium mutant strains 
2.1.3.1  rfa mutation 
The presence of rfa mutation is indicated by sensitivity to crystal violet (see section 
1.2.2.2). About three colonies of S. typhimurium auxotrophs and a wild type strain 
were each inoculated in 6mL of labelled sterile nutrient broth (See Appendix A). The 
inoculated broths were incubated at 37oC overnight.  Each strain was spread plated 
on MH agar and a disc containing 10µL of 0.1% crystal violet placed on the surface 
of the plates. The plates were inverted and incubated overnight at 37oC. A clear zone 
of inhibition observed around the crystal violet disc for S. typhimurium auxotroph, 
confimed the presence of rfa mutation. The virulent strain however, was resistant to 
crystal violet. 
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2.1.3.2  R factor plasmid (pKM101) 
The presence of pKM101 in S. typhimurium confers ampicillin resistance (see 
section 1.2.2..3). About three colonies of S. typhimurium auxotroph and wild type 
strain were each inoculated in 6mls of sterile nutrient agar broth . The broths were 
incubated at 37oC overnight and used for the spread plating on MH agar plates. A 
disc containing 10µg Ampicillin (Sigma-Aldrich, Australia) was placed on the 
surface of each plate. The plates were inverted and incubated overnight at 37oC. 
Ampicillin resistance of Salmonella typhimurium auxotroph was indicated by growth 
around the ampicillin disc. The S. typhimurium wild type strain had clear zone of 
inhibition around the disc using the CDS method (Bell, 1975). 
2.1.3.3  Histidine and Biotin requirement 
Four sets of glucose minimal (GM) agar plates (see Appendix A) were prepared for 
each S. typhimurium auxotroph and S. tyhimurium virulent strain. For the first set of 
plates, 4 drops of sterile 5% Biotin solution was added to the middle of the plates. 
The solution was then spread on the entire surface of the plates using a sterile 
spreader. The second set of plates had 4 drops of sterile 5% Histidine and the third 
set contained a mixture of 5% Biotin and Histidine. The fourth plate did not contain 
any of these supplements. After overnight incubation, growth of S. typhimurium 
auxotroph was observed on the third plate only which was supplemented with 5% 
Biotin and Histidine, validating the mutants as histidine and biotin-dependent. The 
virulent strain on the other hand, had grew on all the four plates. 
2.1.4  Medicinal plant products and Storage 
The medicinal plant products used for the test were aqueous extracts obtained from 
the Ghanaian marketplace in Accra(Table 3). They are finished products packaged in 
bottles and sealed. The products were indicated for conditions such as malaria, 
typhoid fever, diabetes, piles, candidiasis, asthma, anaemia and arthritis.   The plant 
extracts were freeze dried into powder form using a ScanVac CoolSafe freeze dryer 
(Fisherbiotic, Australia). The powdered products were labelled, sealed tightly and 
stored at 4oC until needed. A total number of nine products were freeze dried. 
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2.1.5  Determination of protein content of products 
Estimation of the protein concentration of the medicinal plant products was 
determined by the Lowry et al. (1951) method using a 96-well microtitre plate 
method with bovine serum albumin (BSA) as the standard. The reagent  used were 
0.5mL of 1% copper (II) sulphate, 0.5mL of 2% sodium potassium tartrate and 50mL 
2% sodium carbonate in 0.1N sodium hydroxide (biuret reagent) and 2N Folin-
Ciocalteu’s phenol reagent (see Appendix A). 
Bovine Serum Albumin (BSA) was used to construct the standard curve for use in 
the quantification of the protein content of the commercial medicinal plant extracts. 
One milligram (1mg) of BSA was dissolved in 1mL of distilled water to obtain a 
final concentration of 1mg/mL protein. A serial dilution was prepared from the stock 
from 0, 1, 2.5, 5, 10 to a final protein concentration of 20µg/mL. 
One hundred microliter (100µL) of each standard dilution was added to each well of 
a 96 well microtitre plate and the test samples were also added to their respective 
labelled wells. Two hundred microliter (200µL) of the Biuret reagent was added to 
each of the standard and sample wells, mixing upon each addition with repeated 
pipetting. The plate was then incubated at room temperature for 10-15 minutes.  
Twenty microliter (20µL) of the diluted Folin-Ciocalteu’s phenol reagent was added 
to each well with repeated pipetting upon each addition. The plate was incubated for 
30 minutes after which the absorbance was read at 650nm using Enspire multimode 
plate reader (PerkinElmer, Germany). 
A standard curve was prepared from the absorbance readings of the standard 
solution. The concentration of the test samples were calculated from the standard 
curve. This was done by plotting the absorbance readings of the products on the 
standard curve and tracing it against the protein standard concentration.  
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Figure 2: Protein content showing absorbance at 650nm (y-axis) against concentration in µg/mL (x-axis). Values are 
represented as mean±SEM of three replicates 
2.1.6 Determination of Carbohydrate (CHO) content of products 
Carbohydrate content of the products was measured by the Phenol sulphuric acid 
method by Dubois et. al. (1956) using glucose as a standard. 
Standard concentration of glucose was made in ten different concentrations ranging 
from 10-100 µg/mL. Dilutions of the test samples were prepared to a final volume of 
0.5mL  per test tube. One half of a millilitre (0.5mL) of 5% Phenol was added to 
each tube. The tubes were incubated at room temperature for 5 minutes. This was 
followed by the addition of 2.5mL of concentrated sulphuric acid (H2SO4), which 
was rapidly and directly added to the surface of the solution in a fume hood without 
touching the sides of the tubes. The tubes were mixed by vortexing and then placed 
in a water bath at 100oC for 10 minutes. The tubes were then allowed to cool to room 
temperature. 
Absorbance was measured using a spectrophotometer at 490nm against an 
appropriate reagent blank which contained distilled water in the place of glucose. A 
standard curve was prepared from the absorbance readings and CHO concentrations 
of test samples determined from standard curve. This was done by plotting the 
absorbance readings of the products on the standard curve and tracing it against the 
CHO standard concentration.  
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Figure 3: Carbohydrate content showing absorbance at 4900nm (y-axis) against glucose concentration in µg/mL (x-axis). 
Values are represented as mean±SEM of three replicates 
2.1.7 Preparation of Microsomal Fraction and Quantification of 
Cytochrome P450  
2.1.7.1 Preparation of Microsomal Fraction from Pig liver 
Fresh pig liver was obtained from the butchers’ shop and the microsomal fraction 
was prepared according to the method described by Omura and Sato (1964) with 
slight modifications. The liver weighing about 65.5g was cut into small portions. The 
portions were divided to two groups. One litre of cold sodium chloride (0.9%) 
solution was added to one part of the liver portion (32.25g). For the second part, 
cytochrome P450 inducer, rifampin (ThermoFisher, Australia) was added to 1litre of 
cold sodium chloride (0.9%) solution at 3.275mg/L. Both samples were covered and 
allowed to perfuse overnight at 4oC.  
The liver samples were then removed from the perfusion fluid and rapidly transferred 
into 1.15% ice-cold potassium chloride solution (Sigma, Australia).  Each portion 
was finely sliced and gently homogenised in a sterile mortar and pestle with 4 
volumes ice-cold 1.15% potassium chloride solution. The homogenate was 
centrifuged in a refrigerated centrifuge (Avanti J-E, Beckman coulter USA) at 
20,000g for 25 minutes at 4oC. The floating fat layer was carefully removed and the 
supernatant microsomal fraction decanted. The precipitate was discarded. The 
microsomal fraction was again centrifuged at 100,000g for 90minutes at 4oC in an 
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ultracentrifuge (Optima XE-100 Ultracentrifuge, Beckman Coulter USA). The 
supernatant was discarded and the microsomal pellet resuspended in 4 time ice-cold 
1.15% potassium chloride. The suspension was again centrifuged in the 
ultracentrifuge at 100,000g for 90 minutes at 4oC. The supernatant was discarded and 
the pellet resuspended in 1.15% of ice-cold potassium chloride solution at a 
concentration of 10mg/ml microsome. The samples were stored at -80oC. Protein 
content of the microsome was determined by the Lowry method (Lowry et al, 1951) 
2.1.7.2    Quantification of Total Cytochrome P450 using  the 
Ferrous CO versus Ferrous Difference Spectrum 
2.1.7.2.1 Solubilization of Microsomal Fraction 
The microsomal fraction was solubilized in a buffer which consisted of 100mM 
potassium phosphate buffer (pH 7.4) containing 0.1mM EDTA, 20% glycerol, 0.5% 
sodium cholate and 0.5% Triton X100 (non-ionic detergent). 
 
2.1.7.2.2 Quantification of Total Cytochrome P450 
Total P450 content of the microsomal fraction was measured using the Ferrous CO 
verses Ferrous difference Spectrum according to the method by Guengerich et al 
(2009) with slight modifications. Four hundred microliter (400µL) of the sample was 
diluted with 600µL of the solubilzation buffer in two separate 1cm quartz cuvettes. 
About 1mg of sodium dithionite (the amount at the tip of a small spatula used for this 
purpose) was added to both cuvettes. The cuvettes were covered with parafilm and 
inverted without vigorous shaking to mix the contents. Both cuvettes were placed in 
a UV-2400 PC Series spectrophotometer (Shimadzu, China) and the baseline 
between 400 and 500nm was recorded. The sample cuvette was removed from the 
spectrophotometer and CO gas was slowly bubbled through the sample at the bottom 
of the cuvette for about thirty seconds at one bubble per second in a fume hood. The 
sample cuvette was placed back to its original position in the spectrophotometer and 
the absorbance was recorded between 400 and 500 nm for a several minutes. 
The Cytochrome P450 concentration was calculated by the following formula: 
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(∆A450 - ∆A490) / 0.091 = nmol of P450/mL, where 0.091 is the Extinction 
Coefficient . The final concentration was expressed as P450 per mg protein 
(Guengerich et al, 2009). 
2.1.8 Ames test Protocol 
2.1.8.1 Test Principle 
The test employs histidine-dependent S. typhimurium strains (his- autotrophs), each 
carrying mutation in different genes in the histidine operon. When these autotrophs 
are grown on minimal agar plates containing a trace of histidine, only those strains 
that revert to histidine independence will grow showing visible colonies. 
Spontaneous mutation occurs with each strain, however, with the addition of a 
mutagen, the number of revertant colonies increases in a dose-dependant manner.  
2.1.8.2 Tester Strain Media 
M9 minimal agar plates used for the test was prepared from M9 salts, magnesium 
sulphate (1M), 20% glycerol, calcium chloride (1M) and 14g/L bacteriological agar 
(see Appendix A). The top agar for the overlay preparation was made from 6g/L 
bacteriological agar and 5g/L sodium chloride (see Appendix A). 
2.1.8.3 S9 Fraction and S9 Mix 
The S9 fraction was made from pig liver (see section 2.7). The S9 mix is a mixture of 
S9 microsome and co-factors (D-Glucose-6-phosphate, 1.6g/L, NADP, 3.5g/L, 
Magnesium sulphate, 1.8g/L, potassium sulphate, 2.7g/L, sodium phosphate dibasic, 
12.8/L and sodium phosphate monobasic, 2.8g/L). (See Appendix A). 
2.1.8.4 Dose Determination  
Two dose levels of the products were prepared based on their protein and 
carbohydrate contents. The minimum dose based on the average the protein 
concentrations was 1mg/mL and the maximum dose based on highest carbohydrate 
concentrations of products was 8mg/mL. 
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2.1.8.5 Control and Standardization  
All strains were tested with positive mutagenic chemicals to demonstrate the validity 
of the assay system and positive controls. The positive mutagenic chemicals were 
acridine orange (10µg/mL), sodium azide (1µg/mL) and neutral red (10µg/mL) for 
un-induced test and 2-aminoanthracene (10µg/mL) for S9 induced test. The negative 
control was sodium phosphate buffer, pH 7.4 (See Appendix A) 
2.1.8.6 Experimental Procedure 
The Ames test was performed using the pre-incubation method (Mortelmans and 
Zeiger, 2000). Two to three colonies of each bacterial strain was inoculated in 6mls 
of nutrient broth (Oxoid No 2). The broths were incubated at 37oC for 12-20 hr.  
Sterile test tubes were labelled for each test extract and controls. One hundred 
microliter (100µL) of each sample were added to their appropriate tubes followed by 
100µL of the tester strains. Five hundred microliter (500µL) of phosphate buffer was 
added to the all the tubes for the non-metabolic step. In the metabolic activation 
system, 30% S9 Mix was prepared and kept on ice just before the test, which was 
added in place of the buffer. All tubes were mixed by vortexing and incubated for 20 
minutes at 37oC. Pre-dried GM plates (90mm diameter) were labelled with the 
appropriate test samples. The top agar (18mL/bottle) was melted and supplemented 
with 2mL of 0.05mM histidine/biotin solution (see Appendix A) for each media 
bottle. The bottle was mixed by inverting. The top agar mixture (2.5mL) was added 
to each tube containing test samples (final volume of broth culture,700µl), mixed and 
poured on the surface of the appropriately labelled GM agar plate allowing it to 
spread evenly on the plates. After the top agar had solidified, the plates were 
incubation for 48-72 hr at 37oC. All test were done in triplicates The revertant 
colonies were counted using colony counter (Gallenkamp, England) and the results 
expressed as mean number of revertants per plate for each test sample. 
2.2 Antimicrobial Activity of Medicinal Plant Products 
2.2.1 Medicinal Products 
The nine medicinal extracts used for the antimicrobial activity testing were aqueous 
medicinal products from the Ghanaian marketplace. These were processed and stored 
until needed as shown in section 2.1.4. 
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2.2.2 Microorganisms 
The microorganisms used for the antimicrobial test consisted of Klebsiella 
pneumoniae, Streptococcus agalactiae, Acinetobactor baumannii, Moraxella 
catarrhalis, Streptococcus pyogenes, Salmonella typhimurium, Escherichia coli, 
Pseudomonas aeruginosa, Candida albicans, Bordetella parapertussis, Methicillin-
resistant and Methicillin-sensitive Staphylococcus aureus (MRSA and MSSA). 
These organisms were clinical isolates obtained from the Microbiology Service 
Section, School of Biomedical Sciences, Curtin University through the help of Mr. 
Alain Delhaize. 
2.2.3 Cultivation and Storage of Microorganisms 
A single colony of C. albicans, K. pneumoniae, S. typhimurium, E. coli, 
P.aeruginosa, MRSA and MSSA obtained was inoculated onto their respective 
labelled Muller Hinton (MH) plates. The plates were incubated at 37oC for 24hr. S. 
pyogenes, S. agalactiae, A. baumannii, M. catarrhalis and B. parapertussis were 
inoculated onto blood agar plates and incubated at 37oC for 24hr except B. 
parapertussis which was incubated in an enclosed container with moist tissue and 
incubated for 48hr. Several colonies from the overnight cultures were each 
inoculated in duplicates into vials containing plastic beads immersed in 
cryopreservative fluid (Thermo Fisher, Australia). The vials were inverted about ten 
times for emulsification of the colonies. The cryopreservative fluids were then 
removed before storage of the  isolates at -80oC freezer. 
2.2.4 Agar diffusion test 
Antimicrobial activity of the extracts was performed by the agar-well diffusion 
method as described by Magaldi et al (2004). Fresh cultures of the isolates were 
made on MH and blood agar. 2-3 colonies of the microbial isolates were inoculated 
into 3.5mL of sterile saline solution. These were incubated overnight at 37oC. After 
the overnight incubation, turbidity of the suspensions were adjusted to 0.5 McFarland 
standards (1.5x108 cfu/mL).  A lawn inoculum of each isolate was made on either 
MH (C. albicans, K. pneumoniae, S. typhimurium, E. coli, P.aeruginosa, MRSA and 
MSSA) and blood agar (S. pyogenes, S. agalactiae, A. baumannii, M. catarrhalis and 
B. parapertussis) plates using sterile cotton swabs. The plates were labelled and a 
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6mm well was made in each plate using a sterile cork borer of 6mm diameter. One 
hundred microlitre (100µL) of each extract (2mg/mL) was added to their respective 
labelled wells. The plates were then refrigerated at 4oC for 2hr to allow diffusion of 
extracts to the culture medium. After the diffusion of extracts, the plates were 
incubated at 37oC for up to 24hr except  B. parapertussis which was incubated for 
48hr in a moist enclosed container. The zones of inhibition were measured using a 
measuring rule and all test were done in triplicates. The antibiogram of the isolates 
were also determined to ascertain the resistance/susceptibility of isolates to 
antibiotics. This was done using the calibrated dichotomus sensitivity test, CDS- 
method by  Bell (1975). The CDS disc method of antibiotic sensitivity testing 
(calibrated dichotomous sensitivity test). Pathology, 7(4 Suppl): Suppl 1-48. 
2.2.5  Determination of MIC of the Commercial Ghanaian Medicinal Plant 
Products 
The minimum inhibitory concentration (MIC) of product with antimicrobial activity 
was determined using the 96-well microdilution method (Koneman, 2006, CLSI, 
2012). In this  test, a stock solution of 20mg/mL of product was prepared. Two 
hundred microliter (200µl) of extract was added to the first well of the microtitre 
plate. A two-fold dilution of the extract was made  from the first well by serially 
diluting 100µL of the extract in 100µL of Brain Heart infusion broth from the second 
well to the eleventh well, giving a concentration of 2mg in the first well  to 0.002mg 
in the eleventh well (2000µg to 1.953µg). The twelfth well was left as the solvent 
control. In this test,  sterile distilled water was used as solvent control for the extracts 
and DMSO as solvent control for antibiotics used. Trimethoprim and Cephalexin 
were used as standard antibiotic controls. These were also serially diluted as the 
extracts from 500µg (first well) to 0.488µg (eleventh well). The plates were 
incubated at 37oC for 24 hr. All tests were done in triplicate. After overnight 
incubation at 37oC, 40µL of 0.2mg/ml p-iodonitrotetrazoliumviolet (INT) was added 
to all the wells and the plates examined within 30 minutes for bacterial growth. 
Bacteria growth was indicated by the red colour of INT reducing to formazan. The 
lowest concentration at which decrease in the red colour was apparent compared to 
the next dilution was taken as the MIC value. To determine the minimum inhibitory 
concentration (MBC), all wells with no visible growth were inoculated on agar plates 
and incubated overnight at 37oC. Plates were observed for growth after incubation, 
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the lowest concentration at which there was no growth on the agar plate was 
considered the MBC value. 
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Abstract 
 
The mutagenic potential of medicinal plants commonly sold on the Ghanaian market 
was evaluated in this study. The plant formulations were aqueous extracts prepared 
by the manufacturers from a combination of two or more plants. The Mutagenicity 
tests were conducted on a total of nine herbal formulations using 
Salmonella/microsome bacterial reverse mutation assay (Ames test) with or without 
metabolic activation. The Salmonella typhimurium mutant strains used for the test 
were TA98, TA100 and TA1537. None of the products tested indicated a positive 
mutagenic effect on the mutant Salmonellae strains. One of the extracts, E8 
containing a combination of aqueous extracts from Clausena anisata, Pilostigma 
thonningii, Trichilia monadelpha, Khaya senegalensis and Nauclea latifolia showed 
a 2-fold  decrease in revertant colonies compared to that of the negative controls for 
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all strains in the metabolic activation assay, indicating the potential antimutagenic 
activity of extract. 
Key words: Mutagenicity, Medicinal plants, Salmonella typhimurium, Ames test, 
Ghanaian marketplace 
 
Introduction 
 
Medicinal plants have been in use since time immemorial by traditional healers for 
the treatment and management of many health conditions. Medicinal plants have also 
been found to contain bioactive compounds in many plants extracts which accounts 
for their medicinal properties [1]. Based on their long-term use without sufficient 
scientific data on their safety or toxicity, it is generally believed that herbal 
medicines are safe or have low toxicity. However, recent reports on the adverse 
reactions to herbal medicine ([2], [3], [4], [5], [6]) and mutagenic potential of some 
plant extract ([7], [8], [9], [10]) raises concern over the long-term use of some 
medicinal plants.  
The aim of this study was to screen commonly marketed herbal medicinal products 
on the Ghanaian market for their mutagenic potential using the bacterial reverse 
mutation assay (Ames test). This test is a correlate of compounds that may cause 
cancer. The ideal method to assess the carcinogenic potential of products including 
foods, therapeutic drugs including medicinal plants is to test their ability to form 
tumors in animals, an expensive proposition. 
A brief description of the medicinal plants used in different extracts is as follows: 
 
Nauclea latifolia (Sm): This plant, a member of the Rubiaceae family, is a multi-
stemmed shrub or small tree which is also cultivated worldwide. It is commonly 
called African peach or pin cushion tree, used traditionally for the treatment of 
diarrhoea, malaria, hepatitis and stomach disorders ([11], [12], [13]). 
 
Phyllanthus fraternus (Webster): This medicinal plant, a member of the 
Euphorbiaceae, is native to the Amazon rain forest and India. It is glabrous herb used 
in the treatment of intestinal disorders, viral infections, jaundice, dysentery, stomach 
ache and the management of diabetes ([14], [15], [11]). 
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Cryptolepis sanguinolenta: Cryptolepis sanguinolenta belongs to the family 
Periplocaceae and commonly found in West Africa. It is a shrub used traditionally in 
the treatment of malaria, urinary tract infections, upper respiratory infections, 
hypertension and inflammatory disease ([16], [17]). 
 
Ocimum gratissimum: Ocimum gratissimum is a member of the Laminaceae 
(Labiatae) which is native to Africa, Western India and Asia. It is an aromatic herb 
commonly known as basil or tea bush. It is traditionally used in the treatment of skin 
diseases, cough, upper respiratory infections, malaria, snake bites, diarrhoea and 
dysentery ([18], [11]). 
  
Cnestis ferruginea (Vadhl) D.C: This medicinal plant which is commonly found in 
tropical regions especially West Africa, is a member of the family Connaraceae It is 
a shrub used in the treatment of urethral discharge, gynaecological conditions, skin 
and wound infections, headache and sinusitis ([19], [20], [11]). 
 
Paullinia pinnata: Paullinia pinnata is a member of Sapindaceae family, common in 
tropical Africa, America and Madagascar. It is commonly called bread or cheese 
plant. It is used for the treatment of peptic ulcer, female infertility, asthma, and 
cough. It is also used to control blood pressure and as an aphrodisiac ([21], [22], 
[11]). 
 
Vernonia amygdalina (Del.): Vernonia amygdalina is commonly called bitter leaf 
and belongs to the family Asteraceae. It is a perennial shrub which is widespread 
over Africa. Aside its use as food and chewing stick, it is also used in the treatment 
of conditions such as kidney diseases, measles, malaria, cataract, onchorcerciasis, 
yellow fever and helminthiasis ([23], [24], [25], [11]). 
 
Momordica charantia: Momordica charantia is a tropical plant commonly found in 
Africa, Asia and parts of the Amazon. It is a member of the Cucurbitaceae family 
commonly called bitter melon, African or wild cucumber or bitter gourd. Aside from 
its use as food, M. charantia is also used in the treatment of hypertension, chicken 
pox, hepatitis, rheumatoid arthritis, lupus, glucosuria and as a contraceptive ([26], 
[11] [27]). 
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Strophanthus hispidus (DC): Strophanthus hispidus, also called arrow poison. A 
hairy climbing shrub found in savannah woodlands and a member of the 
Apocynaceae family. Extracts of the plant are used in the treatment of venereal 
diseases, arthritis, rheumatic disease and oedema ([28], [11]). 
 
Lippia multiflora: Lippia multiflora is a member of the Verbenaceae family and is 
native to tropical West Africa. It is a herby shrub commonly called Gambia tea bush. 
L. muliflora is used in the treatment of gastrointestinal infections, high blood 
pressure, analgesic and a muscle relaxant ([19], [11], [29]). 
 
Khaya senagalensis: Khaya senegalensis is a large tree belonging to the Meliaceae 
family. It is native to Africa and commonly called African Mahogany. K. 
senegalensis is traditionally used as a bitter tonic, for the treatment of malaria, boils, 
arthritis and as anthelmintic ([21], [19], [17], [11]). 
 
Kigelia africana: Kigelia africana belongs to the family Bignoniaceae and is widely 
distributed across Africa. It is commonly called sausage tree and used traditionally 
for the management of epilepsy, elephantiasis, worm infestations and haemorrhoids 
([30], [31]). 
 
Mitragyna stipulosa (DC.) Kuntze: Commonly called African linden, M. stipulosa is 
a large tree belonging to the Rubiaceae family and native to West Africa. It is used in 
the treatment of inflammatory conditions, diarrhoea, female infertility and skin ulcer 
([11], [32], [33]). 
 
Chlorophora excelsa (Welw) Benth: Chlorophora excelsa is a member of the 
Moraceae family and is native to Africa. It is a large tree commonly called African 
teak, and is used traditionally in the treatment of conditions such as rheumatism and 
cough associated with bronchitis. It is also used as antibacterial and anti-
inflammatory agent ([34], [35]). 
 
Monodora myristica: Monodora myristica belongs to the family Annonaceae, native 
to Africa and commonly called calabash nutmeg.  It is a branching tree used in the 
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treatment of anaemia, sexual weekness, hypertension, malaria and stomach ache 
([36], [19], [37], [38]). 
 
Alchonia cordifolia: Alchonia cordifolia belongs to the Euphorbiaceae family and 
also known as Christmas bush. It is widely distributed across Africa, and is used for 
treating intestinal parasites, dermatitis, herpes zoster, ringworm, peptic ulcer and 
whooping cough ([39], [40], [41]). 
 
Terminalia ivorensis: This medicinal plant is a member of the Combretaceae family 
and native to West Africa. It is a large tree commonly called black afara. It is used 
traditionally for wound healing and rheumatism ([19], [42], [43]). 
 
Clausena anisata: Clausena anisata is a deciduous shrub or small tree belonging to 
the Rutaceae family and commonly called horsewood or maggot killer. It is usually 
found in savannah, riverine and secondary forest. C. anisata is used for treating 
fungal infections of both skin and mouth. It is also used in the management of high 
blood pressure, epilepsy and as a mosquito repellent ([44], [45]). 
 
Piliostigma thonningii: Also known as camel’s foot, P. thonningii is a member of 
the Fabaceae family and commonly found in Sub-humid Africa and Asia. It is used 
in the treatment of hookworm infections, respiratory diseases, dysentery and snake 
bites ([46], [47]). 
 
Trichilia monadelpha: Trichilia monadelpha belongs to the Meliceae family and is 
commonly found on river banks in Africa. It is used in the treatment of rheumatism, 
diarrhoea, yaws, inflammation, arthritis and as an abortifacient ([21], [19]). 
 
Mussaenda erythropylla: Mussaenda erythrophylla is a climbing shrub belonging to 
the Rubiaceae family. It is native to tropical Africa and India and is commonly called 
Ashanti blood or red flag. It is used for treating cough, jaundice and as a diuretic 
([11], [48]). 
 
Anthoscleista nobilis: Anthoscleista nobilis belongs to the Loganiaceae family and 
commonly called cabbage tree or cabbage palm. It is usually found in tropical 
 89 
 
rainforest of West Africa and used traditionally in the treatment of dysentery, 
diabetes mellitus, abdominal pains, diarrhoea and abdominal pains ([49], [50], [51], 
[52]). 
 
Desmodium adscendens (Sw.) DC: Desmodium adscendens is a weedy perennial 
herb belonging to the Fabaceae family. It is found across the Amazon forest, West 
Africa and South America. It is used in the treatment of infantile diarrhoea, excessive 
urination, gonorrhoea, asthma and epilepsy. ([53], [54], [11]). 
Materials And Methods 
Medicinal Plant Products 
Medicinal plant products used in this study were purchased from the Ghanaian 
marketplace already prepared by the various herbal manufacturers and consisted of 
combinations of aqueous extracts (Table 1). The products were indicated for a 
variety of diseases such as malaria, typhoid fever, diabetes, piles, candidiasis, 
asthma, anaemia and arthritis.  The herbal products were freeze dried into powder 
forms using a ScanVac coolsafe freeze dryer (Fisherbiotic, Australia) and 
reconstituted into 1mg and 8mg /mL concentrations according to their protein or 
carbohydrate concentrations. Extracts were stored in the refrigerator at 4oC until 
needed. 
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Table 1  Medicinal products (Extracts) and their plant constituents 
Extract Plant Constituents 
E1 Nauclea latifolia, Phyllanthus fraternus, Cryptolepis sanguinolenta 
 
E2 Ocimum gratissimum, N. latifolia, C. sanguinolenta 
 
E4 Cnestis ferruginea, Paullinia pinnata 
 
E5 Momordica charantia Vernonia amagdalina,  Strophanthus hispidus, 
Lippia multiflora 
 
E6 Khaya senegalensis, Kigelia africana, Mitragyna stipulosa 
 
E7 Monodora myristica, Chlorophora excelsa,  Alchornea cordifolia, 
K. senegalensis 
 
E8 Clausena anisata, Pilostigma thonningii, Trichilia monadelpha, 
K. senegalensis, N. latifolia 
 
E9 Anthoscleista nobilis, Mussaenda erythrophylla,  Vernonia amygdalina 
 
E10 Desmodium adscendens 
 
E=extract 
Bacterial Strains 
Salmonella typhimurium mutant strains (TA98, TA100, TA1537) previously 
developed by reference [55], were obtained from the Microbiology Service Section, 
School of Biomedical Sciences, Curtin University. The S. typhimurium mutant 
strains were histidine-dependent with either frameshift or base-pair substitution 
defects.  
 
Table 2 Characteristics of Salmonella typhimurium mutant strains used* 
Salmonella 
Strain 
Affected 
Gene 
DNA 
Repair 
LPS Biotin 
Requirement 
R Factor 
Plasmid 
Mutational 
Event 
TA98 hisD3052 uvrB rfa bio- pKM101 Frameshift 
TA100 hisG46 uvrB rfa bio- pkM101 Base-pair 
substitution 
TA1537 hisC3076 uvrB rfa bio- - Frameshift 
 91 
 
*Described in Ames BN, Lee FD, Durston WE. (1973). “An improved bacterial test 
system for the detection and classification of mutagens and carcinogens”. Proc Natl 
Acad Sci, USA. 70:782-786 
Experimental Design 
Bacterial Reverse Mutation Assay (Ames test) 
Glucose minimal (GM) agar plates of 90mm diameter were prepared using 
bacteriological agar (14g/L), M9 salts, 5x (Sigma Aldrich), 20% glycerol, 
Magnesium sulphate (2mL of 1M solution) and calcium chloride (100µL of 1M 
solution). Top agar was prepared using bacteriological agar (6g/L) and sodium 
chloride (5g/L). Histidine/Biotin solution was 0.05mM. S9 Mix was prepared prior to 
the start of test from S9 fraction and co-factors solution containing glucose-6-
phospate (Sigma-aldrich, Australia), nicotinamide adenine dinucleotide phosphate 
(Roche, Australia), magnesium chloride, potassium chloride, sodium phosphate 
monobasic and dibasic (Sigma-aldrich, Australia). 
The Ames test was performed by the pre-incubation method according to the method 
described by Mortelmans and Zeiger, 2000 [56]. Two to three colonies of each 
bacterial strain were inoculated in 6mls of nutrient broth (Oxoid No 2). The broths 
were incubated at 37oC for 12-20 hr. One hundred microliter (100µL) of each sample 
was added to their appropriate tubes followed by 100µL of the tester strains. In the 
non-metabolic activation test, 500µL of sodium phosphate buffer (pH 7.4) was added 
to sample tubes and control whilst the metabolic activation system had 500µL of 
30% S9 Mix added in place of the buffer. All tubes were mixed by vortexing and 
incubated for 20 minutes at 37oC. Two millilitres (2mL) of histidine/biotin solution 
was added to 18mL of molten top agar and the content mixed by inverting. Two and 
a half millilitres (2.5mL) of the top agar mixture was added to each tube containing 
test samples (total broth culture of 700µl), mixing after each addition and 
immediately pouring content onto the surface of the appropriate labelled GM agar 
plate allowing it to spread evenly on the plates. The plates were allowed to set for 
thirty minutes before incubation at 37oC for 48-72 hr. All tests were done in 
triplicates. A lawn of bacteria growth was observed with revertant colonies appearing 
on the surface. The revertant colonies were counted using colony counter 
(Gallenkamp, England) and the results expressed as mean number of revertants per 
plate for each test sample. 
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Preparation of Microsomal Fraction from Adult Pig liver 
Fresh pig liver was obtained from the butchers’ shop and the microsomal fraction 
was prepared according to the method described by Omura and Sato, 1964 [57]. The 
liver was cut into small portions and divided into two. l litre of cold sodium chloride 
(0.9%) solution only was added the first portion. The second portion had cytochrome 
P450 inducer, rifampin (ThermoFisher, Australia) added to 1litre of cold sodium 
chloride (0.9%) solution at 3.275mg/L concentration. Both samples were covered 
and allowed to perfuse overnight at 4oC. After the overnight perfusion, liver samples 
were removed from the perfusion fluid and rapidly transferred into 1.15% ice-cold 
potassium chloride solution (Sigma, Australia).  Each portion was finely sliced and 
gently homogenised using a sterile mortar and pestle with 4 volumes ice-cold 1.15% 
potassium chloride solution. The homogenates were centrifuged in a refrigerated 
centrifuge (Avanti J-E, Beckman coulter USA) at 20,000g for 25 minutes at 4oC. The 
floating fat layer was carefully removed and the supernatant microsomal fraction 
decanted. The microsomal fraction was centrifuged at 100,000g for 90minutes at 4oC 
in an ultracentrifuge (Optima XE-100 Ultracentrifuge, Beckman Coulter USA). The 
supernatant was discarded and the microsomal pellet resuspended in 4 volumes ice-
cold 1.15% potassium chloride. The suspension was again centrifuged in the 
ultracentrifuge at 100,000g for 90 minutes at 4oC. The microsomal pellet was 
resuspended in 1.15% of ice-cold potassium chloride solution at a concentration of 
10mg/ml microsome. The samples were stored at -80oC. Protein content of the 
microsome was determined by Lowry et al., 1951 method [58]. 
 
Quantification of Total Cytochrome P450 content 
Total cytochrome P450 content of the microsomal fraction was measured using the 
ferrous CO verses ferrous difference Spectrum according to the method by 
Guengerich et al., 2009 [59]. 400µL of the sample was diluted with 600µL of 
solubilzation buffer in two separate 1cm quartz cuvettes. The buffer consisted of 
100mM potassium phosphate buffer (pH 7.4) containing 0.1mM EDTA, 20% 
glycerol, 0.5% sodium cholate and 0.5% Triton X100 (non-ionic detergent). About 
1mg of sodium dithionite was added to both cuvettes. The cuvettes were covered 
with parafilm and inverted without vigorous shaking to mix the contents. Both 
cuvettes were placed in a UV-2400 PC Series spectrophotometer (Shimadzu, China) 
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and the baseline between 400 and 500nm was recorded. The sample cuvette was 
removed from the spectrophotometer and CO gas was slowly bubbled through the 
sample at the bottom of the cuvette for thirty seconds at one bubble per second in a 
fume hood. The sample cuvette was placed back to its original position in the 
spectrophotometer and the absorbance was recorded between 400 and 500 nm for 
several minutes. The Cytochrome P450 concentration was calculated using the 
following formula according to reference [59]: 
(∆A450 - ∆A490) / 0.091 = nmol of P450 per mL, where 0.091 is the Extinction 
Coefficient (∆ɛ450 -490). The final concentration was expressed as P450 per mg 
protein. 
Date analysis 
The results of the Ames test was interpreted using a non-statistical method based on 
the 2-fold rule by Mortelmans and Zeiger, 2000 [56]. An extract is considered 
mutagenic (positive mutagen) if it produces a 2-fold or more dose related increase in 
revertant colonies compared to that of the negative control (spontaneous mutation). 
The extract is considered to be non-mutagenic if there is no dose-related 2-fold 
increase in revertants and inconclusive where there is slight increase in revertants but 
cannot be considered positive or negative.   
 
Results 
Total Cytochrome P-450 Quantification test 
The result of the total cytochrome P-450 measurement is shown on Figure 1 A and 
B.  Figure A represents S9 fraction only and Figure B is S9 activated by rifampin. 
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A) 
 
B 
 
Fig 1. Absorbance spectrum of the microsomal fraction showing absorbance peak at 450nm (wavelength) with S9 only (A) and 
S9+Rifampin (B) 
The fact that the total quantity of P450 was increased from 1.063 nmol / mg protein 
for non-profused S9 microsomal fraction prepared from pig livers to 1.777 nmol / mg 
protein for livers perfused with rifampin indicates activation of microsomal enzymes. 
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Ames test results 
 
A 
 
B 
 
C 
Figure 2: Extract E8 showing anti-mutagenicity outcome compared to control at 8mg/mL for S9 activated and S9+Rifampin 
activated P450 with S. typhimurium strains TA98(A) ,TA100 (B) and a negative mutagenicity outcome for TA1537(C). 
Standard inducers: 2-aminoanthracene (10µg/plate). The values are represented as mean±SEM for three replicates 
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A 
 
B 
 
C 
Figure 3: Mutagenicity of extract E1 showing absence of his revertants (negative outcome)of S9 activated versus S9+Rifampin 
activated P450 using TA98(A), TA100 (B) and TA1537 (C). Standard inducer , 2-aminoanthracene (10µg/plate). The values are 
represented as mean±SEM for three replicates 
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Discussion 
Results from the Ames test of the Ghanaian medicinal plant products did not indicate 
any  positive mutagenic effect on the mutant strains used for test. However, extract 
E8 which had been prepared by the herbal manufacturer from aqueous mixture of 
Clausena anisata, Nauclea latifolia, Khaya senegalensis, Piliostigma thonningii and 
Trichilia monadelpha was found to produce a 2-fold decrease in revertant colonies 
compared to the negative controls in both the metabolic activation systems of TA98 
and TA100. Clearly, the antimutagenicity activity must be confined to one or more 
medicinal plants used for the preparation of E8. This was, a clear indication of the 
potential antimutagenicity of extract E8. Methanol lominoid fraction isolated from 
Khaya senegalensis had been previously reported to exhibit anti-cancer activity for 
human colon cancer cell lines, human breast cancer cell lines and cervical cancer cell 
lines at 2-200 parts per million (ppm) [60]. Significant free-radical scavenging 
activity of aqueous and ethanolic extracts of this medicinal plant has also been 
reported, using a 1,1, diphenyl-2picryl-hydrazyl (DPPH) test at 1.28 to 21µg/mL 
[61].  A similar antioxidant and free-radical scavenging activity of K. senegalensis 
methanol extract at 500mg/mL has also been reported Atawodi et al., 2009 [62]. On 
the other hand, an alkaloid rich chloroform fraction isolated from Nauclea latifolia 
was reported to have produced some mutagenicity in the Ames spot test with TA 97 
and TA 100 at 10µg. Furthermore, the fraction exhibited an anti-proliferative activity 
on human monocytes at the same concentration [13]. Hydro-methanolic saponin 
fractions isolated from the plant has also been association with DNA-damage and 
chromosome mutations in Chinese Hamster ovary cells at 2-10µg [63]. Clausena 
anisata fraction, chalepin was reported to be non-mutagenic in an Ames spot test at 
500µg [64]. However, the ethanol extract of Piliostigma thonningii has been reported 
to have antioxidant and free radical scavenging activity in vivo against carbon 
tetrachloride-induced hepatic and oxidative damage in Albina rats at 10, 100 and 
200mg/kg body weight [65]. Methanol extract of the plant was also non-toxic at 10-
5000µg/mL in a brine shrimp lethality assay [66]. Extracts of Trichilia monadelpha, 
ethyl acetate, petroleum ether and ethanol also exhibited free radical scavenging 
activity at 0.1-3mg/mL in a DPPH and reducing power assay [67]. Although Nauclea 
latifolia is reported to have some mutagenic activity, its toxic effect in E8 appears to 
have been suppressed potentially by unknown interactions with the bioactives 
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produced by the other four plants in the extract. The antimutagenic results obtained 
from the test could be attributed to the reported antioxidant activities of the four plant 
components in the mixture. Other studies have shown a correlation between 
antioxidant and free radical scavenging activity of plants and their anti-mutagenicity. 
([68], [69]).  
It is now important to determine the medicinal plant constituent (s) of E8 aqueous 
extract responsible for the antimutagenic activity. It is also  important that after 
identification of the plant constituent responsible for mutagenicity, further tests on 
cytotoxicity are conducted using a selection of human cell lines to determine the anti-
cancer properties of E8. 
Conclusion 
The aim of this study was to screen commonly marketed Ghanaian medicinal plant 
products for mutagenicity using the bacterial reverse mutation assay (Ames test). 
None of the products tested indicate any positive mutagenic effect, whilst extract E8 
was found to have exhibited an antimutagenic effect. Further studies are warranted to 
identify the plant constituent (s) responsible for the antimutagenicity of E8 and  
cytotoxicity test conducted to determine the anti-cancer properties of the extract E8. 
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Chapter Four 
Supplementary Information for Commonly Marketed 
Herbal Extract Formulations Demonstrating Negative 
Outcomes in the Ames test 
 
The Ames test results are interpreted using the 2-fold rule by Mortelmans and Zeiger 
(2000) as stated in chapter three. Accordingly, an extract is considered mutagenic 
(positive mutagen) if it produces a 2-fold or more increase in revertant colonies 
compared to that of the negative control (spontaneous mutation), and negative for 
mutagenicity if there is no 2-fold or more increase in revertant colonies over negative 
control. Ames test results for Extracts E2, E4, E5, E6, E7, E9 and E10 which were 
found to be negative for mutagenicity. The results are presented on Figures 4 A-C to 
10 A-C. 
 
4.1 Extract E2  
Results of Extract E2 for both un-induced (without metabolic activation) and induced 
(S9 activated and S9+Rifampin activated) are presented in Figure 4 for all three S. 
typhimurium strains tested (TA98, TA100 and TA1537). Compared to their controls, 
TA98 (A), TA100 (B) and TA1537(C) did not show any 2-fold increases in revertant 
colonies at both concentrations of 1mg/mL and 8mg/mL (Fig A-C), and hence not 
mutagenic. The CFUs were not 2 fold lower than the controls and hence were not 
antimutagenic. 
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A 
 
B 
 
C 
FIG 4: Extract E2 showing negative mutagenicity outcomes compared to control for TA98(A), TA100(B) and TA1537(C). 
Standard controls, without metabolic activation (un-induced) = Acridine orange, 10µg/plate (A), Sodium azide, 10µg/plate (B), 
Neutral red, 10µg/plate (C). Standard inducer, with metabolic activation = 2-aminoanthracene, 10µg/plate. The values are 
represented as mean±SEM for three replicates 
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4.2 Extract E4  
Extract E4 results for both un-induced (without metabolic activation) and induced 
(S9 activated and S9+Rifampin activated) are presented in Figure 5 for all three S. 
typhimurium strains tested (TA98, TA100 and TA1537). TA98 (A) and TA1537(C) 
did not show any 2-fold increases in revertant colonies as compared to their control 
at both concentrations of 1mg and 8mg in all test systems. An increase in reversion 
was observed for TA100 (B) at both concentrations for all test systems; however, 
these increases were not up to 2-fold that of the control, and hence not mutagenic. 
The CFUs were not 2 fold lower than the controls and hence were not antimutagenic. 
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B 
 
C 
FIG 5: Extract E4 showing negative mutagenicity outcomes compared to control for TA98(A), TA100(B) and TA1537(C). 
Standard controls, non-metabolic activation  (un-induced) = Acridine orange, 10µg/plate (A), Sodium azide, 10µg/plate (B), 
Neutral red, 10µg/plate (C). Standard inducer, with metabolic activation =  2-aminoanthracene, 10µg/plate. The values are 
represented as mean±SEM for three replicates. 
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4.3 Extract E5  
Extract E5 results for both un-induced (without metabolic activation) and induced 
(S9 activated and S9+Rifampin activated) are presented in Figure 6 for all three S. 
typhimurium strains tested (TA98, TA100 and TA1537). TA98 (A) and TA1537(C) 
did not show any 2-fold increases in revertant colonies as compared to their control 
at both concentrations of 1mg and 8mg in all test systems. There were slight 
increases in reversion for TA100 (B) at both concentrations for all test systems, but 
these increases were not up to 2-fold that of the control, and hence not mutagenic. 
The CFUs were not 2 fold lower than the controls and hence were not antimutagenic. 
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C 
FIG 6: Extract E5 showing negative mutagenicity outcomes compared to control for TA98(A), TA100(B) and TA1537(C). 
Standard controls, non-metabolic activation (un-induced) = Acridine orange, 10µg/plate (A), Sodium azide, 10µg/plate (B), 
Neutral red, 10µg/plate (C). Standard inducer, metabolic activation =  2-aminoanthracene, 10µg/plate. The values are 
represented as mean±SEM for three replicates 
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4.4 Extract E6 
The results for extract E6 results for are presented in Figure 7 for all three S. 
typhimurium strains tested (TA98, TA100 and TA1537) for un-induced (without 
metabolic activation) and induced (S9 activated and S9+Rifampin activated). 
Although some slight increases in reversion was observed for TA98 induced (A), 
TA100 and TA1537, these increases were not up to 2-fold that of the control 
spontaneous revertant colonies, and hence not mutagenic. The CFUs were not 2 fold 
lower than the controls and hence were not antimutagenic. 
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FIG 7: Extract E6 showing negative mutagenicity outcomes compared to control for TA98(A), TA100(B) and TA1537(C). 
Standard controls, non-metabolic activation (un-induced) = Acridine orange, 10µg/plate (A), Sodium azide, 10µg/plate (B), 
Neutral red, 10µg/plate (C). Standard inducer, metabolic activation = 2-aminoanthracene, 10µg/plate. The values are 
represented as mean±SEM for three replicates. 
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4.5 Extract E7  
Results for Extract E7 are presented in Figure 8 for both un-induced (without 
metabolic activation) and induced (S9 activated and S9+Rifampin activated). 
Compared to their controls, TA98 (A) and TA100 (B) did not show any 2-fold 
increases in revertant colonies at both concentrations of 1mg and 8mg in all test 
systems. Slight increases were observed at 8mg/mL for all test systems for TA1537 
(C), however, these increases were not up to 2-fold as compared to the control 
revertant colonies, and hence not mutagenic. The CFUs were not 2 fold lower than 
the controls and hence were not antimutagenic. 
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FIG 8: Extract E7 showing negative mutagenicity outcomes compared to control for TA98(A), TA100(B) and TA1537(C). 
Standard controls, non-metabolic activation (un-induced) = Acridine orange, 10µg/plate (A), Sodium azide, 10µg/plate (B), 
Neutral red, 10µg/plate (C). Standard inducer, metabolic activation = 2-aminoanthracene, 10µg/plate. The values are 
represented as mean±SEM for three replicates. 
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4.6 Extract E9  
The Ames test results for Extracts E9 for both un-induced (without metabolic 
activation) and induced (S9 activated and S9+Rifampin activated) are shown on 
Figure 9. TA98 (A) and TA100 (B) did not show any 2-fold increases in revertant 
colonies at both concentrations whilst there were slight increases of revertants at 1mg 
and 8mg/mL for TA1537 (C) un-induced and at 1mg S9 activated. These increases 
were not up to 2-fold that of the control spontaneous revertants, and hence not 
mutagenic. The CFUs were not 2 fold lower than the controls and hence were not 
antimutagenic. 
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FIG 9: Extract E9 showing negative mutagenicity outcomes compared to controls for TA98(A), TA100(B) and TA1537(C). 
Standard controls, non-metabolic activation  (un-induced) = Acridine orange, 10µg/plate (A), Sodium azide, 10µg/plate (B), 
Neutral red, 10µg/plate (C). Standard inducer, metabolic activation = 2-aminoanthracene, 10µg/plate. The values are 
represented as mean±SEM for three replicates. 
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4.7 Extract E10  
The Ames test results for Extracts E10 for both un-induced (without metabolic 
activation) and induced (S9 activated and S9+Rifampin activated) are shown on 
Figure 10. TA98 (A) and TA100 (B) did not show any 2-fold increases in revertant 
colonies at both concentrations. However, there were slight increases observed at 
1mg and 8mg/mL for TA1537 un-induced and at 8mg/mL S9+Rifampin activated 
which were not up to 2-fold that of the control spontaneous revertants. 
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FIG 10: Extract E10 showing negative mutagenicity outcomes compared to control for TA98(A), TA100(B) and TA1537(C). 
Standard controls, non-metabolic activation (un-induced) = Acridine orange, 10µg/plate (A), Sodium azide, 10µg/plate (B), 
Neutral red, 10µg/plate (C). Standard inducer, metabolic activation = 2-aminoanthracene, 10µg/plate. The values are 
represented as mean±SEM for three replicates. 
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Abstract 
Nine Ghanaian medicinal plant products commonly sold on the Ghanaian 
marketplace were tested for their antimicrobial activity on selected clinical bacterial 
isolates at a concentration of 2mg/mL, using the agar well diffusion method. From 
the results, one out of the nine products screened (E8) exhibited antimicrobial 
activity against Moraxella catarrhalis, giving a mean inhibition zone diameter of 
20.7±1.2mm. The product is prepared by the herbal manufacturer from combination 
of five different medicinal plants (Khaya senegalensis, Nauclea latifolia, Pilostigma 
thonningii, Trichilia monadepha and Clausena anisata). All other products showed 
no antimicrobial activity (resistant) against any of the pathogens tested. 
Ciprofloxacin (2.5µg disc) was the most sensitive antibiotic control giving inhibition 
zone diameter of 40±1mm (E.coli), followed by 35.7±1.2mm (S. typhimurium), 
35±1mm (B. parapertussis) and 32±2mm (M. catarrhalis). The minimum inhibitory 
concentration (MIC) of E8 was 125µg. The minimum bactericidal concentration of 
E8 was 500µg whereas that of the antibiotic controls was 125µg for both Cephalexin 
and Trimethoprim. 
Keywords: Medicinal plants, antimicrobial activity, Moraxella catarrhalis, 
Ghanaian medicinal plants, Agar well diffusion test 
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Introduction 
Herbal medicine is widely used, especially in developing countries because it is 
readily available and affordable. In Ghana, most people depend on herbal medicine 
to meet their basic healthcare needs. It has been found that most plants used in the 
preparation of herbal medicine contain bio-active compounds which are usually 
extracted for human use. Plants can be used in their raw form or as extract (crude 
extract) for medication, a common practice in most developing countries ([1], [2]). 
Herbal medicine plays a significant role in Africa, and has also maintained its 
popularity worldwide. About 80% of African and Asian population including Ghana 
use herbal remedies as alternative to orthodox medicine for their primary health care. 
Whilst in the developed countries, 70% to 80% of the population has used 
complementary or alternative medicine. Herbal medicine is usually the first line of 
treatment  for about 60% of children with malaria in countries like Ghana, Nigeria, 
Zambia and Mali [3]. This is because herbal medicine is easily accessible, affordable 
and is ingrained in their everyday life and well-being. Almost all parts of plants are 
used for medicinal purposes, especially the roots, whole plants, barks, flowers, leaves 
and stem. Medicinal plants have many uses, such as antimicrobials ([4], [5]), 
antidiabetic ([6], [7], [8]), anti-atherogenic and anti-ischemic [9], as antioxidants 
([10], [11]), anticancer [12], and as anti-malaria ([13], [14], [15], [16]). In Ghana, it 
is estimated that 951 tons of crude plant medicine (excluding pre-packed herbal 
medicine) are sold annually on the Ghanaian domestic market, amounting to a total 
of US$7.8 million market value and an export value of US$15 million [17]. 
Considering the current trend of antibiotic resistance and the availability of plants 
with bio-active compounds, plant based medicine could serve as alternative to 
conventional medicine. The aim of the study is to screen some selected medicinal 
plant products (pre-packaged) commonly sold on the Ghanaian marketplace for their 
antimicrobial activities. 
Materials And Methods 
Medicinal Plant Products 
The medicinal products used were pre-prepared as herbal medicines which were 
purchased from the Ghanaian market in Accra, Ghana. The products were all 
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aqueous extracts indicated for conditions such as malaria, typhoid fever, diabetes, 
cough, piles, candidiasis, asthma and anaemia. 
Table 1 Medicinal products and their plant constituents              
Extract Plant Constituents 
E1 Nauclea latifolia, Phyllanthus fraternus, Cryptolepis sanguinolenta 
 
E2 Ocimum gratissimum, N. latifolia, C. sanguinolenta 
 
E4 Cnestis ferruginea, Paullinia pinnata 
 
E5 Momordica charantia Vernonia amagdalina,  Strophanthus hispidus, 
Lippia multiflora 
 
E6 Khaya senegalensis, Kigelia africana, Mitragyna stipulosa 
 
E7 Monodora myristica, Chlorophora excelsa,  Alchornea cordifolia, 
K. senegalensis 
 
E8 Clausena anisata, Pilostigma thonningii, Trichilia monadelpha, 
K. senegalensis, N. latifolia 
 
E9  
Anthoscleista nobilis, Mussaenda erythrophylla,  Vernonia amygdalina 
 
E10 
Desmodium adscendens 
E = EXTRACT 
Micro-organisms 
The micro-organisms used for the test were clinical isolates obtained from the 
Microbiology Service Section, School of Biomedical Sciences, Curtin University. 
They consisted of Streptoccocus pyogenes, Streptococcus agalactiae, Klebsiella 
pneumonia, Pseudomonas aeruginosa, Escherichia coli, Moraxella catarrhalis, 
Bordetella parapertussis, Acinetobacter baumannii, Salmonella typhimurium and 
Candida albicans. 
Agar Diffusion Test 
The antimicrobial activity was performed by the agar-well diffusion method [18]. 
The bacteria strains were inoculated into 3.5mL of sterile saline solution from 
overnight-growth cultures on Mueller Hinton and blood agar. The turbidity of the 
bacterial suspensions was adjusted to 0.5 McFarland standards (1.5x108cfu/mL). 
Lawn inoculum of the various bacteria strains were made on their respective agar 
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plates using sterile cotton swabs. A sterile cork borer of 6mm diameter was used to 
create wells on the agar plates and 100µL of each aqueous extracts were added to 
their respective labelled wells. The plates were refrigerated at 4oC for 2 hours to 
allow diffusion of extracts into the medium before incubation at 370C for 24 hours. 
All tests were done in triplicates. Cephalexin and trimethoprim were used as control 
antibiotics for validation of the assay. Antibiograms of the pathogens was also 
determined using the calibrated dichotomous sensitivity test (CDS) as described by 
Bell, 1975 [19]. Antibiotic disks for this test were purchased from Sigma-Aldrich 
(Australia). 
Determination of MIC and MBC of the Commercial Ghanaian Medicinal Plant 
Extracts 
The minimum inhibitory concentration (MIC) was determined by the 96-well 
microdilution method ([20], [21]). Using 100µL/well, a two-fold dilution of the 
extract was made from the stock (20mg/mL) to a concentration of 2mg (2000µg, first 
well) to 0.002mg (1.953µg, eleventh well). Well number twelve was the solvent 
control, water being the control for aqueous extracts and DMSO as control for 
antibiotics without any extract. Trimethoprim and Cephalexin were used as the 
antibiotic controls at concentrations ranging from 500 to 0.488µg. The plates were 
sealed and incubated at 37oC for 24 hr. All tests were done in triplicate. After 
overnight incubation, 40µL of 0.2mg/mL p-iodonitrotetrazoliumviolet (INT) was 
added to all the wells and the plates examined within 30 minutes for bacterial 
growth. Bacteria growth was indicated by the red colour of INT reducing to 
formazan. The lowest concentration at which decrease in the red colour was apparent 
compared to the next dilution was taken as the MIC value. To determine the 
minimum inhibitory concentration (MBC), all wells with no visible growth were 
inoculated on agar plates and incubated overnight at 37oC. Plates were observed for 
growth after incubation, the lowest concentration at which there was no growth on 
the agar plate was considered the MBC. 
Results 
Results of the antimicrobial test of the nine aqueous extracts tested against human 
pathogenic bacteria are presented on Table 2. Product/extract E8 gave a significant 
activity against Moraxella catarrhalis with zone of inhibition of 20±1.2. The 
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antibiotic susceptibility pattern of the microorganisms is shown on Table 3. The MIC 
and MBC  of E8 versus the control antibiotics cephalexin and trimethoprim are 
shown on Table 4. 
Table 2   
ORGANISM E1 E2 E4 E5 E6 E7 E8 E9 E10 
 
Escherichia 
coli 
 
R R R R R R R R R 
Candida 
albicans 
 
R R R R R R R R R 
Moraxella 
catarrhalis 
 
R R R R R R S R R 
Pseudomonas 
aeruginosa 
 
R R R R R R R R R 
Acinetobactor 
baumannii 
 
R R R R R R R R R 
Streptococcus 
agalactiae 
 
R R R R R R R R R 
Salmonella 
typhimurium 
 
R R R R R R R R R 
Klebsiella 
pneumonia 
 
R R R R R R R R R 
Bordetella 
parapertusis 
 
R R R R R R R R R 
Streptocococc
us pyogenes 
 
R R R R R R R R R 
Sensitivity test results showing resistant/sensitivity outcome of products against selected microorganisms Result = mean 
±standard deviation. R = resistant, S = sensitive, E = Extract,  
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Table 3  
ORGANISM E AMP CTX F CN SXT CIP RD FOX 
Escherichia 
coli 
 
NT R S S S S S NT S 
Candida 
albicans 
 
NT NT R R R R R R R 
Moraxella 
catarrhalis 
 
S R R S S S S S S 
Pseudomonas 
aeruginosa 
 
NT R R R S R S NT R 
Acinetobactor 
baumannii 
 
S R R R S R S R R 
Streptococcus 
agalactiae 
 
S S S S S S S S S 
Salmonella 
typhimurium 
 
NT S S S S S S NT S 
Klebsiella 
pneumoniae 
 
NT R S S S S S NT R 
Bordetella 
parapertussis 
 
S R R S S S S R R 
Streptococcus 
pyogenes 
S S S S R R S S S 
Antibiograms for the test pathogens used in this study. Result = Mean±Standard deviation. R = resistant, S = sensitive., NT = 
not tested. E (Erythromycin, 25µg), AMP (Ampicillin,10µg), CTX (Cefotaxime, 5µg), F (Nitrofurantoin, 300µg), CN 
(Gentamicin,  10µg), SXT (Sulphamethoxazole/Trimethoprim, 25µg), CIP (Ciprofloxacin, 2.5µg), RD (Rifampicin, 5µg), FOX 
(Cefoxitin, 10µg). 
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Table 4 Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal 
Concentration (MBC)  of product E8 and controls against M. catarrhalis     
 
           
EXTRACT 
MIC (µg/mL) MBC (µg/mL) 
E8 125 500 
Cephalexin 62.5(S) 125 
Trimethoprim 15.6(S) 125 
E = Extract, S = sensitive 
Discussion 
Results from this study have shown that product E8 has activity against Moraxella 
catarrhalis. M. catarrhalis is known to cause chronic ear infections (otitis media) 
which is a significant public health issue all over the world particularly because of 
the associated antibiotic resistance ([22], [23], [24], [25]) mainly due to biofilm 
formation in the middle ear of infected patients [26]. M. catarrhalis may also cause 
other respiratory infections such as pneumonia, bronchitis, endocarditis, sinusitis and 
chronic obstructive pulmonary disease (COPD) in adults ([23], [27], [25], [28]. In a 
recent study at one of the teaching hospitals in Ghana, M. catarrhalis was found to 
be one of the major bacteria isolates in the sputum samples of adult patients 
hospitalized with cases of community-acquired pneumonia infections. Other 
pathogens contributing to pneumonia were Streptococcus species, Citrobactor 
diversus and Staphylococcus species [29]. 
Extract E8 was prepared by the manufacturer from Khaya senegalensis, Nauclea 
latifolia, Pilostigma thonningii, T. monadelpha and Clausina anisata. Ethanol 
extracts of K. senegalensis has been reported to have shown antimicrobial activity 
against C. albicans [30], E. coli, Salmonella. typhi [31], Bacillus. subtilis, 
Pseudomonas aeruginosa and Enterobactor species ([32], [33]). N. latifolia alcohol 
and aqueous extracts exhibited antimicrobial activity against E. coli, Streptococcus 
pneumoniae, Shigella dysenteriae, S. aureus [34], P. aeruginosa and S. typhi [35]. 
Methanol and flavonoid extracts of P. thonningii was effective against Strptococcus 
pyogenes, S. dysenteriae [36] and S. aureus [37]. The essential oil and crude extracts 
of C. anisata is reported to have antimicrobial activity against Neisseria gonorrhoeae 
[38], Cryptococcus neoformans, Candida tropicalis, Candida krusei and Candida 
parapsilosis [39]. It is also reported to be active against Shigella species, Proteus 
species, Aspergillus niger and Aspergillus parasiticus [40]. Information in relation to 
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the antimicrobial activity of T. monadelpha has not been reported.  None of the plant 
constituents of E8 has so far been reported to have antimicrobial activity against M. 
catarrhalis. Although individual plant components of the product E8 have been 
reported to possess antimicrobial activities, the product was inactive against most of 
the microorganisms tested. This could be due to the different methods used in the 
preparation of extract (organic vs aqueous) or an antagonistic effect of a plant 
constituent. 
It is now important to determine the medicinal plant constituent(s) of the E8 aqueous 
extract that are responsible for the observed bactericidal activity against M. 
catarrhalis. After identification of the plant constituents responsible for the 
antimicrobial activity, it will be highly desirable to compare the performance of the 
bactericidal function of the aqueous extract by oral versus topical versus 
intratympanic delivery, initially using a laboratory animal model, best suited for 
effective treatment of otitis media. This is not notwithstanding the opportunity 
arising from this research for isolation of the relevant bioactive compound(s) 
permitting standardisation of effective dose of the extract for treatment of infections 
caused by M. catarrhalis. 
Conclusion 
The role of medicinal plants in the treatment of various disease conditions since time 
immemorial cannot be overstated. The aim of this study was to screen pre-packaged 
medicinal plant products commonly sold on the Ghanaian marketplace for their 
antimicrobial activity.  One out of the nine products screened (E8) was significantly 
active against M. catarrhalis in vitro. Generally, most medicinal plant products are 
produced by combination of two or more plants with the belief that their activity or 
effect may be enhanced (synergy). This belief cannot be verified until the medicinal 
plant constituent (s) responsible for the antimicrobial activity is /are identified. 
Further in vitro evaluation of individual plant constituents responsible for 
antimicrobial activity of extract E8 against M. catarrhalis is highly warranted. 
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Chapter Six  
General Discussion 
Herbal medicine is widely used, especially in developing countries such as Ghana, 
where there is a dual system of medical practice which recognises both conventional 
and herbal medicine. It is estimated that about 951 tons of crude herbal mixture 
(excluding pre-packed herbal medicine) are sold annually on the Ghanaian domestic 
market, amounting to a a total of US$7.8 million market value and an export value of 
US$15 million (van Andel, Myren and Onselen, 2012). Though herbal medicine has 
been in use over a long period of time, sufficient scientific data supporting its effect 
on claimed human ailments is limited. While current research efforts on the 
therapeutic potential of Ghanaian medicinal plants focus mainly on the screening for 
phytochemical constituents, antimicrobial efficacy, and toxicity, there is the need to 
investigate both potential benefits as well as deleterious effect of these herbal 
medicinal products as these can be inherently dangerous if they contain therapeutic 
levels of toxic constituents which are not screened for in the manufacturing process. 
6.1 Mutagenic Potential of the Medicinal Plant Products 
All the Ghanaian medicinal plant product formulations, representing a mixture of 
aqueous extract of different medicinal plants were found to be non-mutagenic using 
the three strains (TA98, TA100 and TA1537). However, extract E8 which was 
prepared by the herbal manufacturer from a combination of C. anisata, P. thonningii, 
T. monadelpha, N. latifolia and K. senegalensis showed potential antimutagenic 
effects in vitro against the TA98 and TA100.  
Extract E8, that was produced by the herbal manufacturer from an aqueous mixture 
of C. anisata, N. latifolia, K. senegalensis, P. thonningii and T. monadelpha, 
produced a 2-fold decrease in revertant colonies compared to the negative controls in 
both the with and without metabolic activation systems of TA98 and TA100. Clearly, 
the antimutagenic activity must be confined to one or more medicinal plants used for 
the preparation of E8. Aqueous and methanol extracts of K. senegalensis have been 
reported to exhibit 2,2, diphenyl-2picryl-hydrazyl (DPPH) free radical scavenging 
activity at 1.28 to 21µg/mL (Lompo et al, 2007). A similar antioxidant and free-
radical scavenging activity of K. senegalensis methanol extract at 500mg/mL has 
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also been reported (Atawodi et al, 2009). This plant had previously been reported to 
exhibit anti-cancer activity for human colon cancer, human breast cancer and 
cervical cancer cell lines at 2-200 parts per million (ppm) (Zhang et al, 2007).On the 
other hand, an alkaloid rich chloroform fraction isolated from N. latifolia was 
reported to have produced some mutagenicity in the Ames spot test with TA 97 and 
TA 100 at 10µg. The extract also exhibited an anti-proliferative activity on human 
monocytes (Traore et al, 2000). Hydro-methanolic saponin fractions isolated from 
the plant have also been associated with DNA-damage and chromosome mutations in 
Chinese Hamster ovary cells at 2-10µg (Liu et al, 2011). Clausena anisata fraction, 
chalepin was reported to be non-mutagenic in an Ames spot test at 500µg (Uwaifo, 
1984). However, the ethanol extract of P. thonningii has been reported to exhibit 
antioxidant and free radical scavenging activity in vivo against carbon tetrachloride-
induced hepatic and oxidative damage in Albina rats at 10, 100 and 200mg/kg body 
weight (Taofeek, 2011). Methanol extract of the plant was also non-toxic at 10-
5000µg/mL in a brine shrimp lethality assay (Ajaiyeoba et al, 2006). Extracts of T. 
monadelpha, ethyl acetate, petroleum ether and ethanol also exhibited free radical 
scavenging activity at 0.1-3mg/mL in a DPPH and reducing power assay (Ben et al, 
2013). Although N. latifolia is reported to have some mutagenic activity, its toxic 
effect in E8 appears to have been suppressed potentially by unknown interactions 
with bioactives produced by the other four plants in the extract. The antimutagenic 
results obtained from the test could be as a result of the reported antioxidant 
activities of the four plant components in the mixture. Other studies have shown a 
correlation between antioxidant and free radical scavenging activity of plants and 
their antimutagenicity. (Gow-Chin and Hui-Yin, 1995; González-Avila et al, 2003).  
 
Extract E1 was prepared by the herbal manufacturer from an aqueous mixture of N. 
latifolia, P. fraternus and C. sanguinolenta. Ethanol extract of C. sanguinolenta 
compound, cryptolepine has been reported to be cytotoxic on P388 murine human 
leukemia cell lines (Dassonnevillu et al, 2000). Cryptolepine also caused DNA 
damage in human lymphocytes, whilst inducing mutations in chinese hamster lung 
fibroblast cell lines (Ansah, et al., 2002: Gopalan et al, 2011). Phyllanthus fraternus 
hydro-alcoholic extract is reported to have antioxidant activity on superoxide radicals 
and alcohol-induced oxidative stress in liver mitochondria of rats (Santos et al, 
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2000). Aqueous extract of the plant also showed a similar antioxidant activity by 
altering lipid peroxidation and glutathione levels in oxidative stress rat brain (Naga et 
al, 2008). On the other hand, N. latifolia had earlier chloroform fraction was reported 
to have produced some mutagenicity in the Ames spot test with TA 97 and TA 100 at 
10µg. Furthermore, the fraction exhibited an anti-proliferative activity on human 
monocytes at the same concentration (Traore et al, 2000). The negative mutagenic 
results from extract E1 could be attributed to the potential antioxidant activity of a 
component of the mixture, which suppressed the toxic effect of other plants present 
in the mixture. 
 
Extract E2 is prepared by the herbal manufacturer from aqueous mixture of O. 
gratissimum, N. latifolia, and C. sanguinolenta. Methanol leaf extract of O. 
gratissimum showed antimutagenic activity, inhibiting His- to His+ reverse-mutation 
induced by ethyl methanesulfonate against Salmonella typhimurium TA100 
(Obaseiki-Ebor et al., 1993). Both methanol hexane extracts also showed antioxidant 
activity by scavenging DPPH free radical (Akinmoladun et al, 2007: Oboh et al, 
2008). Ocimum gratissimum aqueous extract had inhibitory effect on human breast 
tumour growth (Hangia-Makker et al, 2007). DNA damaging and cytotoxicity effect 
of C. sanguinolenta has been reported (Ansah et al, 2002: Wright et al, 2001: Miert 
et al, 2005). N. latifolia also reportedly produced mutagenic effect with strains TA 97 
and TA 100 (Traore et al, 2000) and DNA damaging with chromosomal mutations in 
mammalian cells (Liu et al, 2011). The mutagenicity test of extract E2 in this study 
was negative for all strains of bacterial used. This could be due to the antagonistic 
effect resulting from the combination of the three plants making them less toxic to 
the bacterial cells. 
 
Extract E4 was prepared by the herbal manufacturer from a mixture of C. ferruginea 
and P. pinnata. The negative mutagenicity results of extract E4 obtained in the Ames 
test is consistent with reported literature, as none of the plant components had been 
reported for mutagenicity. Cnetis ferruginea methanol extract has been reported to 
produce negative results in a bacterial reverse mutation assay (Hong and Lyu, 2011) 
whilst its aqueous leaf extract was also reported by Garon et al (2007) to be 
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cytotoxic. Methanol, aqueous and ethanol extracts of this plant has also been 
reported by Akharaiyi et al, (2012) and Oke and Hamburger, (2001) to have 
antioxidant activity against DPPH free radical. Paullinia pinnita methanol extract 
exhibited DPPH free radical scavenging activity (Annan et al, 2009: Jimoh et al, 
2007).  
 
Extract E5 is prepared from an aqueous combination of M. charantia, V. 
amagdalina, S. hispidus and L. multiflora. Momordica charantia hexane and aqueous 
extracts exhibited antioxidant activity whilst reducing carcinogen-induced lipid 
peroxidation in the liver and DNA damage in lymphocyte (Semiz and Sen, 2007: 
Sharma et al, 2011). Vernonia amagdalina ethyl acetae and petroleum ether extract is 
reported to have exhibited antimutagenic activity against S. typhimurium strains 
TA100 at 20µg/plate (Obaseiki-Ebor et al, 1993). It also has anticancer activity 
human adenocarcinoma cells (Yedjou et al, 2008). Furthermore, Lippia multoflora 
methanol exhibited moderate cytotoxic effects on human breast adenocarcinoma 
MCF-7 and human lung carcinoma COR L23 cell lines (Ajaiyeoba et al, 2006). The 
combined effect of the four extracts produced a negative results for mutagenicity test. 
This result is therefore consistent with previous studies (Obaseiki-Ebor et al, 1993). 
which have not shown any mutagenic effect of any of the plant components of the 
extract. 
 
Extract E6 was prepared by the herbal manufacturer from combination of aqueous 
extract of K. senegalensis, K. africana and M. stipulosa. Khaya senegalensis 
methanol has been reported to have anti-cancer activity against human breast cancer, 
human colon cancer and cervical cancer cell lines (Zhang et al, 2007), whilst the 
hexane extract of the root and stem-bark had free radical scavenging activity 
(Atawodi et al, 2009). Kigelia africana ethanol extract gave negative results for S. 
typhimurium strains TA98 and TA100 without metabolic activation at 500µg 
(Kolodziej, 1997). A similar negative results of methanol extract of the plant against 
TA98 and TA100 at 5, 0.5 and 0.05mg/mL was reported by Elgorashi et al, (2003). 
Also, triterpine derivative compounds isolated from ethanol extract of M. stipulosa 
had been reported to be cytotoxic (Tapondjou, 2002). The combined effect of plants 
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in product E6 was negative with or without metabolic activation at all concentrations. 
This is consistent with previous studies (Elgorashi et al, 2003: Kolodziej, 1997) with 
strains TA98 and TA100 without metabolic activation.  
 
Extract E7 has M. myristica, C. excelsa, A. cordifolia and K. senegalensis as its main 
component as prepared by the herbal manufacturer. The combined effect of the 
plants in this mixture gave negative results for mutagenicity for all strains used, 
which is consistent with results of other aqueous extracts (E1-E9) yielding the same 
outcome. Methanol extract of Mitragyna myristica is reported to have exhibited low 
cytotoxic activity on MRC-5 human diploid embryonic lung cell (Kekana-Douki et 
al, 2011). However, the ethanol and methanol extract of this plant has also been 
reported to have DPPH and hydroxyl free radical scavenging activity (Ogunmoyole 
et al, 2012: Uyoh et al, 2013). Methanol extract of A. cordifolia gave a negative 
mutagenicity results with strains TA 98, TA100, TA1535, TA1537 and E.coli 
WP2uvrA at 625, 2,500 and 5000µg/plate respectively (Hong and Lyu, 2011). 
Chlorophora excelsa dimethyl formamide extract also gave a negative results in the 
Ames test for mutagenic or antimutagenic potential for TA97 at 205 and 75mg/ml 
(Padayachee and Odhav, 2001). Khaya senegalensis  has earlier been reported to 
have anti-cancer and antioxidant activity (Atawodi et al, 2009: Kayser and Abreu: 
Zhang et al, 2007). It appears, therefore, that aqueous extracts of the plant 
constituents of this herbal medicine formulation do not posess mutagenic or 
antimutagenic potential. 
 
Extract E9 is composed of three medicinal plants, V. amygdalina, M. erythrophylla 
and A. nobilis prepared in aqueous form by the herbal manufacturer did not yield any 
mutagenic or antimutagenic potential. Vernonia amagdalina ethyl acetate, methanol 
and petroleum ether extracts has earlier been reported to have exhibited 
antimutagenic activity with S. typhimurium strains TA98 and TA100 at 200µg/plate 
(Obaseiki-Ebor et al, 1993).  Anthscleista nobilis methanol extract is reported to have 
DPPH free radical scavenging activity (Annan and Dickson, 2008). The negative 
mutagenicity results observed for E9 may have been  due to difference in method of 
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extraction viz., water versus organic solvent or due to an antagonistic effect of a 
plant constituent in the cocktail formulation. 
Extract E10 was prepared by the herbal manufacturer from prepared D. adscendens. 
This plant is reported to have DPPH free radical scavenging activity well and weakly 
cytotoxic on A375 melanoma cells (Konan et al, 2012: Mѐnan et al, 2006: Muanda et 
al, 2011). Desmodium adscendens has not yet been reported to be mutagenic, which 
is consistent with the results obtained from this study. 
 
In summary, there was no evidence for mutagenic potential for any of the nine 
aqueous products tested this investigation. However, antimutagenic potential of E8 
was evident regardless of the use of native or activated microsomal enzymes 
prepared from adult pig liver. The specific plant constituent (s) responsible for this 
activity need to be identified as a potential aid in the treatment of cancer. 
 
6.2 Antimicrobial Activity of the Medicinal Plant Products 
Evaluation of the antimicrobial activity test of the Ghanaian medicinal plant product 
formulations showed that extract E8 possessed antimicrobial activity against 
Moraxella catarrhalis. Due to the significance of M. catarrhalis in the aetiology of 
chronic ear infections (otitis media) and respiratory infections (pneumonia, 
bronchitis, endocarditis, sinusitis and chronic obstructive pulmonary disease) in 
adults, further studies aimed at identifying the plant constituent(s) responsible for the 
observed antimicrobial activity are required (Murphy and Parameswaran, 2009; 
Cappelletty, 1998, Mikucha, et al., 2000; Ruff, 1998). Studies on the ethanol, 
methanol or flavonoid extracts of K. senegalensis, N. latifolia, P. thonningii, T. 
monadelpha and C. anisata, plant constituents of E8 are also warranted because of 
their reported broad-spectrum antimicrobial activities against Streptococcus 
pyogenes, S. dysenteriae (Akinpelu and Obuotor, 2000), S. aureus (Ibewuike et al., 
1997), C. albicans, E. coli, Salmonella. typhi, Bacillus. subtilis, Pseudomonas 
aeruginosa and Enterobactor species (Abalaka et al. 201: Idu and Igeleke, 2012; 
Kudi et al. 1999: Oseni and Osman, 2012).  
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Whilst the essential oil and crude extracts of C. anisata are reported to have 
antimicrobial activity against Neisseria gonorrhoeae (Geyid et al. 2005), 
Cryptococcus neoformans, Candida tropicalis, Candida krusei and Candida 
parapsilosis (Hamza et al. 2006), aqueous extract formulation showed antimicrobial 
against Aspergillus niger and Aspergillus parasiticus (Osei-safo, 2010). 
 
It is thus clear from the present investigation that different methods for extraction of 
antimicrobial bioactives will need to be evaluated for antimicrobial activity against 
pathogens of interest and significance to the community. 
. 
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Chapter Seven 
Conclusion and Future Direction 
7.1 Conclusions 
As stated in the introduction, the aims embodied in this Mphil project were: 
 To screeen commonly marketed herbal medicinal products on the Ghanaian 
market for their mutagenic potential using the bacterial reverse mutation 
assay (Ames test) 
 To determine the antimicrobial properties of commonly marketed Ghanaian 
medicinal plant formulations 
 
A.  Investigation of the mutagenic potential of the aqueous extracts of the 
commonly marketed Ghanaian medicinal plant product formulation carried 
out using Ames test for mutagenicity revealed all tested extracts to be non-
mutagenic.  
 
B. Extract E8 which had been produced by the herbal manufacturer from an 
aqueous mixture of C. anisata, N. latifolia, K. senegalensis, P. thonningii and 
T. monadelpha, produced a 2-fold decrease in revertant colonies compared to 
the negative controls in both the metabolic activation systems of TA98 and 
TA100, a clear indication of a potential antimutagenic activity, which must be 
confined to one or more medicinal plants used for the preparation of E8. No 
investigation was carried out to determine the possible mechanism of 
antimutagenicity of extract E8. However, it may be attributable to possible 
antioxidant and/or free radical scavenging activity of one or more of the plant 
constituents in the herbal formulation 
 
C. The antimicrobial activity of the Ghanaian medicinal plant product 
formulations, extract E8 was demonstrated to possess significant activity 
against Moraxella catarrhalis, a causative agent of chronic ear infections 
(otitis media) in infants and other respiratory infections in adults. None of the 
other extracts showed activity against any of the microorganisms tested. The 
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minimum inhibitory concentration of E8 was 125µg/well and the minimum 
bactericidal activity was 500µg/well. It is also important to note that none of 
the plant constituents of extract E8 has so far been reported to have 
antimicrobial activity against M. catarrhalis (See Chapters 1, section 1.2 and 
Chapter 5, pages 126-127). 
 
7.2 Future Directions 
 It is recommended that the medicinal plant constituent(s) of E8 aqueous 
extract responsible for the antimutagenic activity be determined  
 After identification of the plant constituent responsible for mutagenicity, 
further tests on cytotoxicity should be conducted using a selection of human 
cancer cell lines to determine the anti-cancer properties of E8. 
 It is important to determine the medicinal plant constituent(s) of the E8 
aqueous extract that are responsible for the observed antimicrobial activity 
against M. catarrhalis 
 The route of delivery in vivo, of E8 constituent(s) responsible for bactericidal 
and antimutagenic activities should be determined, initially using appropriate 
laboratory animal models 
 After validating the antimicrobial and antimutagenic activities of E8 in vivo, 
it will be feasible to identify and isolate the compounds responsible for the 
antimicrobial and antimutagenic activites for further development as potential 
antibiotics or drugs for treatment of select carcinomas. 
7.3 Study limitations 
 The concentrations of the products used for the mutagenicity test were chosen 
based on their protein and carbohydrate contents. As such, one low and one 
high concentration was tested. This was based on the assumption that a 
product which did not show any activity at a high concentration was unlikely 
to show any activity at a lower concentration. 
 Only the herbal formulation that showed antimicrobial activity in the agar 
diffusion test was subjected to further test for MIC/MBC, as is traditionally 
done. 
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APPENDIX A 
Reagents used for Preparation of Different types of Growth Media used in this 
Project. 
M9 Salts (5X)  
Na2HPO4.7H2O    33.9g/L 
KH2PO4     15g/L 
NH4Cl      5g/L 
NaCl      2.5g/L 
56.4g of M9 salts (Sigma-Aldrich, Australia) was dissolved in 1L of Milli Q water, 
then autoclaved at 121ᴼC and 15psi. Once autoclaved, the M9 salt solution was kept 
in water bath at ≈55°C. 
1M MgSO4 
12.04g of MgSO4 was dissolved in 100mL of Milli Q water, then autoclaved at 
121ᴼC and 15psi. 
1M CaCl2 
11.1g of CaCl2 was dissolved in 100mL of Milli Q water, then autoclaved at 121ᴼC 
and 15psi. 
20% Glycerol 
20mL of glycerol was added to 80mL of Milli Q water, mixed and autoclaved at 
121ᴼC and 15psi. 
Glucose Minimal Agar (GM) 
14g of bacteriological agar No 1(Oxoid, Australia) was dissolved in 700mL Milli Q 
water, and then autoclaved 121ᴼC and 15psi. Once the temperature was ≈ 55°C, the 
following sterilised solutions were added: 
M9 Salts (5X)    200mL 
MgSO4    2mL 
20% Glycerol    20mL 
CaCl2     1µL 
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The agar was mixed by swirling upon each addition and contents poured into sterile 
petri dishes (100X15mm). The plates were allowed to set and sterility was checked 
by overnight incubation at 37°C. 
Top Agar 
Bacteriological agar No 1  1.2g 
NaCl     1g/L 
Milli Q water    200mL 
1.2g of bacteriological agar was dissolved in 200mL Milli Q water by heating. 1g of 
NaCl was then added to the agar mixing to dissolve. The top agar was distributed 
into 36mL aliquots then autoclaved 121ᴼC and 15psi.  
 
Histidine/Biotin Solution, 0.5mM  
D-Biotin    24.8mg 
L-Histidine    19.2mg 
Milli Q water    200mL 
24.8mg of D-Biotin was added to boiling water to dissolve. Then after, 19.2mg of L-
Histidine was added to the solution to dissolve. After cooling, the Histidine/Biotin 
solution was sterilised using 0.22µm filter.    
 
Sodium Phosphate Buffer Solution (0.1mM), pH 7.4 
Sodium phosphate monobasic 6.9g 
Sodium phosphate dibasic  7.1g 
6.9g of sodium phosphate monobasic was dissolved in 500mL of Milli Q water. 7.1g 
of sodium phosphate dibasic was also dissolved separately in 500mL of Milli Q 
water. 60mL of the sodium phosphate monobasic solution was added to 440mL 
solution of sodium phosphate dibasic solution, making a total volume of 500mL and 
pH adjusted to 7.4 using a pH meter. 
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Co-factor Solution for S9 Microsome 
Co-factor solution for the S9 microsomal fraction was prepared from the following 
chemicals:  
D-Glucose-6-phosphate  0.8g 
NADP     1.75g 
MgCl     0.9g 
KCl     1.35g 
Sodium phosphate dibasic  6.4g 
Sodium phosphate monobasic 1.4g 
These were dissolved in 450mL Milli Q water and sterilised with 0.22µm filter. The 
solution was stored in 7mL aliquots at -20°C. 
Reagents for estimation of carbohydrate content 
Phenol Sulphuric acid 
5% Phenol    0.5mL 
Concentrated H2SO4    2.5mL 
Reagents for Protein Estimation (Lowry Method) 
Biuret reagent 
1% CuSO4    0.5mL 
2% KNaC4H4O6   0.5mL 
2% Na2CO3 in 0.1N NaOH  50mL 
 
Folin-Ciocalteuś Phenol reagent 
2N Folin-Ciocalteuś Phenol  1mL 
Milli Q water    1mL 
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Constituents of Nutrient broth 
Peptone A    10g/L 
Beef extract    10g/L 
NaCl     5g/L 
 
Constituents of Mueller-Hinton agar 
Beef infusion solid   2g/L 
Casein hydrolysate   17.5g/L 
Starch     1.5g/L 
Agar     17g/L 
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APPENDIX B 
 Raw Data of Mutagenicity Experiments 
Table B1 - Extract E1 
Mutant 
Strain 
Control Std. 
Induced 
Std. 
Control 
Un-induced S9 Activated S9+Rifampin 
Activated 
  10µg 10µg 1mg 8mg 1mg 8mg 1mg 8mg 
 
TA98 23±0.9 60±0.9 62±1.5 24±0.9 21±1.2 24±1.2 26±0.9 23±0.7 25±1.2 
 
TA100 99±1.2 188±2.1 184±1.8 102±1.5 99±2 99±0.6 104±0.9 108±1.5 115±1.7 
 
TA1537 22±1.3 55±1.5 56±1.2 22±1.2 22±1.5 23±1.5 20±0.6 22±0.6 24±1.5 
 
Results expressed as: Mean ±SEM, Std.: Standard, Standard control: Acridine orange 
(TA98), Neutral red (TA1537), Sodium azide (TA100), Standard Induced: 2-
aminianthracene 
 
Table B2 - Extract E2 
Mutant 
Strain 
Control Std. 
Induced 
Std. 
Control 
Un-induced S9 Activated S9+Rifampin 
Activated 
  10µg 10µg 1mg 8mg 1mg 8mg 1mg 8mg 
 
TA98 23±0.9 60±0.9 62±1.5 27±0.9 25±2.4 26±0.7 24±1.2 26±1.2 31±1.9 
 
TA100 99±1.2 188±2.1 184±1.8 102±1.5 110±0.6 117±2 103±1.5 119±1.9 123±1.2 
 
TA1537 22±1.3 55±1.5 56±1.2 17±1.2 19±1.9 22±0.9 21±1.5 24±1.2 23±1 
 
Results expressed as: Mean ±SEM, Std.: Standard, Standard control: Acridine orange 
(TA98), Neutral red (TA1537), Sodium azide (TA100), Standard Induced: 2-
aminianthracene 
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Table B3- Extract E4 
Mutant 
Strain 
Control Std. 
Induced 
Std. 
Control 
Un-induced S9 Activated S9+Rifampin 
Activated 
  10µg 10µg 1mg 8mg 1mg 8mg 1mg 8mg 
 
TA98 23±0.9 60±0.9 62±1.5 27±0.9 29±0.9 28±0.3 27±0.6 31±0.9 27±0.6 
 
TA100 99±1.2 188±2.1 184±1.8 119±1.5 125±2 122±1.8 105±1.2 125±2 120±0.9 
 
TA1537 22±1.3 55±1.5 56±1.2 19±1.9 18±1 23±0.6 21±1.5 23±1.2 22±1.3 
 
Results expressed as: Mean ±SEM, Std.: Standard, Standard control: Acridine orange 
(TA98), Neutral red (TA1537), Sodium azide (TA100), Standard Induced: 2-
aminianthracene 
Table B4 - Extract E5 
Mutant 
Strain 
Control Std. 
Induced 
Std. 
Control 
Un-induced S9 Activated S9+Rifampin 
Activated 
  10µg 10µg 1mg 8mg 1mg 8mg 1mg 8mg 
 
TA98 23±0.9 60±0.9 62±1.5 25±1 23±0.3 21±1.2 19±0.3 25±1.5 21±1 
 
TA100 99±1.2 188±2.1 184±1.8 120±0.6 124±0.9 121±0.6 101±1.2 123±1.2 121±2.1 
 
TA1537 22±1.3 55±1.5 56±1.2 23±1.2 20±0.9 29±0.9 28±0.6 23±1.2 27±0.6 
 
Results expressed as: Mean ±SEM, Std.: Standard, Standard control: Acridine orange 
(TA98), Neutral red (TA1537), Sodium azide (TA100), Standard Induced: 2-
aminianthracene 
 
Table B5 - Extract E6 
Mutant 
Strain 
Control Std. 
Induced 
Std. 
Control 
Un-induced S9 Activated S9+Rifampin 
Activated 
  10µg 10µg 1mg 8mg 1mg 8mg 1mg 8mg 
 
TA98 23±0.9 60±0.9 62±1.5 20±1.8 22±1.5 29±2.4 23±1.2 32±0.9 29±1.2 
 
TA100 99±1.2 188±2.1 184±1.8 120±0.9 119±0.6 119±1 115±0.6 120±2.5 119±1.9 
 
TA1537 22±1.3 55±1.5 56±1.2 27±1.2 27±1.5 30±0.9 25±0.7 33±0.6 31±0.6 
 
Results expressed as: Mean ±SEM, Std.: Standard, Standard control: Acridine orange 
(TA98), Neutral red (TA1537), Sodium azide (TA100), Standard Induced: 2-
aminianthracene 
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Table B6 - Extract E7 
Mutant 
Strain 
Control Std. 
Induced 
Std. 
Control 
Un-induced S9 Activated S9+Rifampin 
Activated 
  10µg 10µg 1mg 8mg 1mg 8mg 1mg 8mg 
 
TA98 43±1.2 86±1.3 97±1.3 27±1.2 27±0.8 30±0.9 25±0.9 33±0.6 30±0.3 
 
TA100 126±1.5 264±0.8 288±1.5 124±1.8 124±1.8 123±1.5 104±2.6 120±0.3 105±2.4 
 
TA1537 21±0.3 51±1.7 56±1.5 24±0.3 31±1.3 24±0.6 29±0.3 26±1 29±1.2 
 
Results expressed as: Mean ±SEM, Std.: Standard, Standard control: Acridine orange 
(TA98), Neutral red (TA1537), Sodium azide (TA100), Standard Induced: 2-
aminianthracene 
 
Table B7 - Extract E8 
Mutant 
Strain 
Control Std. 
Induced 
Std. 
Control 
Un-induced S9 Activated S9+Rifampin 
Activated 
  10µg 10µg 1mg 8mg 1mg 8mg 1mg 8mg 
 
TA98 43±1.2 86±1.3 97±1.3 34±4.0 30±1.7 35±1.2 19±1.2 36±0.9 12±0.9 
 
TA100 126±1.5 264±0.8 288±1.5 127±4.7 130±1.5 118±1.2 55±2.6 141±0.9 47±1.6 
 
TA1537 21±0.3 51±1.7 56±1.5 25±1.7 17±0.6 28±2.5 23±0.6 17±0.7 13±0.3 
 
Results expressed as: Mean ±SEM, Std.: Standard, Standard control: Acridine orange 
(TA98), Neutral red (TA1537), Sodium azide (TA100), Standard Induced: 2-
aminianthracene 
 
Table B8 - Extract E9 
Mutant 
Strain 
Control Std. 
Induced 
Std. 
Control 
Un-induced S9 Activated S9+Rifampin 
Activated 
  10µg 10µg 1mg 8mg 1mg 8mg 1mg 8mg 
 
TA98 43±1.2 86±1.3 97±1.3 30±1.5 31±0.8 32±0.8 30±1.7 31±1.7 30±0.9 
 
TA100 126±1.5 264±0.8 288±1.5 122±1.5 96±0.9 102±0.7 98±0.6 107±1.5 103±1.2 
 
TA1537 21±0.3 51±1.7 56±1.5 28±1.5 28±1.2 30±2 21±1.2 24±2 20±0.9 
 
Results expressed as: Mean ±SEM, Std.: Standard, Standard control: Acridine orange 
(TA98), Neutral (TA1537), Sodium azide (TA100), Standard Induced: 2-
aminianthracene 
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Table B9 - Extract E10 
Mutant 
Strain 
Control Std. 
Induced 
Std. 
Control 
Un-induced S9 Activated S9+Rifampin 
Activated 
  10µg 10µg 1mg 8mg 1mg 8mg 1mg 8mg 
 
TA98 43±1.2 86±1.3 97±1.3 34±4.0 30±1.7 28±1.2 29±0.9 29±1.2 31±1.2 
 
TA100 126±1.5 264±0.8 288±1.5 120±0 114±0.9 130±0.6 114±3.8 123±1.5 124±1.5 
 
TA1537 21±0.3 51±1.7 56±1.5 29±1.7 30±0 21±2 20±0.6 26±2.7 24±0.7 
 
Results expressed as: Mean ±SEM, Std.: Standard, Standard control: Acridine orange 
(TA98), Neutral red (TA1537), Sodium azide (TA100), Standard Induced: 2-
aminianthracene 
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Table B1 - Protein Content of Ghanaian Medicinal Plant Extracts 
Extract Dilution µg/mL µg/mL x 
dilution 
mg/mL Total 
Volume/Bottle 
(mL) 
Total 
Concentration/ 
Bottle (mg/mL) 
01 1/80 10.8 
 
 
864 0.864 330 285.12 
 
 
02 1/80 1.2 
 
 
96 0.096 350 33.6 
04 1/80 21.6 
 
 
1728 1.728 330 570.24 
05 1/80 3.4 
 
 
272 0.272 500 136 
06 1/100 14.2 
 
 
1420 1.420 330 468.6 
07 1/120 22 
 
 
2640 2.640 500 1320 
08 1/100 20.2 
 
 
2020 2.020 330 666.6 
09 
 
1/100 12.2 
 
 
1220 1.220 500 610 
10 1/100 8.0 
 
 
800 0.8 330 264 
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Table B2 - Carbohydrate Content of Ghanaian Medicinal Plant Extracts 
Extract Dilution µg/mL µg/mL x 
dilution 
mg/mL Total 
Volume/Bottle 
(mL) 
Total 
Concentration/
Bottle (mg/mL) 
01 1/80 47 
 
 
3760 3.76 330 1240.8 
02 1/80 21 
 
 
1680 1.68 350 588 
04 1/80 101 
 
 
8080 8.08 330 2666.4 
05 1/80 28 
 
 
2240 2.24 500 1120 
06 1/80 107 
 
 
8560 8.56 330 2824.8 
07 1/80 110 
 
 
8800 8.80 500 4400 
08 1/80 108.5 
 
 
8680 8.68 330 2864.4 
09 1/80 78 
 
 
6240 6.24 500 3120 
10 1/80 36 
 
 
2880 2.88 330 950.4 
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Raw data for Carbohydrate and Protein Standard Curves 
Table B3 – Carbohydrate standard curve 
Glucose concentration Absorbance at 490nm (±SEM) 
10 0.0085±0.00006 
20 0.017±0.0001 
30 0.028±0.0002 
40 0.0034±0.0001 
50 0.0446±0.0002 
60 0.0579±0.0002 
70 0.0618±0.0001 
80 0.0724±0.00005 
90 0.0818±0.0002 
100 0.089±0.0009 
 
Table B4 – Protein standard curve 
Protein concentration Absorbance at 650nm (±SEM) 
1 0.015±0.0009 
2.5 0.047±0.001 
5 0.089±0.001 
10 0.154±0.0006 
20 0.259±0.001 
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Raw data for antimicrobial susceptibility testing of products and antibiogram 
Table 2  Sensitivity test results of extracts zones of inhibition (mm) 
ORGANISM E1 E2 E4 E5 E6 E7 E8 E9 E10 
 
Escherichia coli 
 
0 0 0 0 0 0 0 0 0 
Candida 
albicans 
 
0 0 0 0 0 0 0 0 0 
Moraxella 
catarrhalis 
 
0 0 0 0 0 0 20±1.2 0 0 
Pseudomonas 
aeruginosa 
 
0 0 0 0 0 0 0 0 0 
Acinetobactor 
baumannii 
 
0 0 0 0 0 0 0 0 0 
Streptococcus 
agalactiae 
 
0 0 0 0 0 0 0 0 0 
Salmonella 
typhimurium 
 
0 0 0 0 0 0 0 0 0 
Klebsiella 
pneumonia 
 
0 0 0 0 0 0 0 0 0 
Bordetella 
parapertusis 
 
0 0 0 0 0 0 0 0 0 
Streptocococcus 
pyogenes 
 
0 0 0 0 0 0 0 0 0 
Result = mean±standard deviation.  0 = no inhibition 
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Table 3 Antibiograms for the test pathogens used in this study 
ORGANISM E AMP CTX F CN SXT CIP RD FOX 
Escherichia 
coli 
 
NT 0 25±1 25±1 20±0 30±2 40±1 NT 20±2 
Candida 
albicans 
 
NT NT 0 0 0 0 0 0 0 
Moraxella 
catarrhalis 
 
27±2 0 10±1.5 36±2 31±1 30±1.5 32±1 23±1.2 25±0 
Pseudomonas 
aeruginosa 
 
NT 0 0 0 16±0 0 28±2 NT 0 
Acinetobactor 
baumannii 
 
16±0 0 0 10±1 19±0.5 0 22±0 0 0 
Streptococcus 
agalactiae 
 
24±0.5 24±1 22±2 24±0 14±1 22±0 16±2 29±0 20±1 
Salmonella 
typhimurium 
 
NT 20±1.5 28±3 25±1 20±0 29±1 36±1 NT 22±0 
Klebsiella 
pneumoniae 
 
NT 0 23±0 20±1 18±0.5 25±3 30±0 NT 10±0 
Bordetella 
parapertussis 
 
25±2 0 0 15±0 30±1 35±0 35±0 0 0 
Streptococcus 
pyogenes 
14±0 31±0 31±0.5 28±2 9±0 0 15±0 18±1 25±1 
Result = Mean±Standard deviation. Zone of inhibition = mm. E (Erythromycin, 25µg), AMP (Ampicillin,10µg), CTX 
(Cefotaxime, 5µg), F (Nitrofurantoin, 300µg), CN (Gentamicin,  10µg), SXT (Sulphamethoxazole/Trimethoprim, 25µg), CIP 
(Ciprofloxacin, 2.5µg), RD (Rifampicin, 5µg), FOX (Cefoxitin, 10µg). 
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APPENDIX C 
Calculations for Estimation of Cytochrome P450 using the Spectral Assay 
Cytochrome P450 concentration is calculated by the following formula (Guengerich 
et al, 2009). 
(∆A450 - ∆A490) / 0.091 = nmol of P450 per ml, where 0.091 is the Extinction 
Coefficient (∆ɛ450 -490). The final concentration is expressed as P450 per mg protein. 
 
Estimation of P450 in the S9 activated fraction 
For S9 activated fraction only, 1/2.5 dilution factor was used in the spectral 
measurement at the protein concentration of 0.4mg/mL. 
(∆A450 - ∆A490) / 0.091  
 (0.01459 – (- 0.00078) = 0.01537 
0.01537 / 0.091 = 0.169 µM P450, x 2.5 = 0.425 µM P450 = 0.425 nmol/mL 
1mL = 0.425 nmol/0.4 mg protein = 1.063 nmol/mg protein 
Therefore the P450 concentration of Sample A = 1.063 nmol/mg protein 
 
Estimation of P450 in the S9 fraction activated by Rifampin  
For S9+Rifampin activated fraction, 1/2.5 dilution factor was used in the spectral 
measurement and the protein concentration was 0.3mg/mL. 
(∆A450 - ∆A490) / 0.091  
 (0.02040 – 0.00102) = 0.01537 
0.01938/ 0.091 = 0.213 µM P450, x 2.5 = 0.533 µM P450 = 0.533 nmol/mL 
1mL = 0.533 nmol/0.3 mg protein = 1.777 nmol/mg protein 
Therefore the P450 concentration of Sample A = 1.777 nmol/mg protein 
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